Advanced search
Publication Cover
Journal of Microencapsulation
Micro and Nano Carriers
Volume 7, 1990 - Issue 2
Submit an article Journal homepage
8
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 275-296 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Development, dissolution and stability of sustained-release ibuprofen microspheres, and microsphere suspensions. ADEYEYE, C. M., University of Georgia, Athens, GA, USA, Dissertation, 1988, 238 pp.
  • Interference-resistant liposome specific binding assay. US Patent 4839276; June 13, 1989. AnoLFsEN, R. H., HEDAYA, E., MAK, C. L., and ScHwAamEac, M., Off. Gaz. US Pat. Trademark Off. Pat., 1989, 1103, (2), 1229.
  • Preparation and evaluation of bovine serum albumin nanospheres coated with monoclonal antibodies. AKASAKA, Y., USDA, H., TAKAYAMA, K., MACHIDA, Y., and NAGAI, T., Drug. Des. Deliv., 1988, 3, (1), 85–97.
  • Preparation and evaluation of controlled-release furosemide microspheres by spherical crystallization. AKBUGA, J., Int. J. Pharm., 1989, 53, (2), 99–105.
  • The in vitro susceptibility of Chlamydia trachomatis L2 to liposome-encapsulated tetracy-cline. AL-AWADHI, H. A., REICH, M., and STOKES, G. V., Abstr. Annu. Meet. Am. Soc. Microbiol., 1989, 89, 28.
  • Lipid-amino acid interactions: a study of tryptophan effects on dipalmitoyl-phosphatidylcholine multilamellar liposomes. ALBERTINI, G., BERTOLI, E., CURATOLA, G., MARIANI, P., RUSTICHELLI, F., and ZOLESE, G., Chem. Phys. Lipids, 1989, 50, (2), 143–153.
  • Trapping drug efficiency in liposomes produced by extrusion of freeze-thaw multilamellar vesicles. ALINO, S. F., GARCIA, M., LEJARRETA, M., BOBADILLA, M., PEREZ-YARZA, G., and UNDA, F. J., Biochem. Soc. Trans., 1989, 17, (6), 1000–1001.
  • Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. ALLEN, T. M., HANSEN, C., and RUTLEDGE, J., Biochim. Biophys. Acta, 1989, 981, (1), 27–35.
  • Recent advances in sustained release of antineoplastic drugs using liposomes which avoid uptake into the reticuloendothelial system. ALLEN, T. M., and MEHRA, T., Proc. West Pharmacol. Soc., 1989, 32, 111–114.
  • The transport of microspheres from the gastro-intestinal tract to inflammatory air pouches in the rat. ALPAR, H. 0., FIELD, W. N., HYDE, R., and LEWIS, D. A., J. Pharm. Pharmacol., 1989,41, (3), 194–196.
  • Properties of magnet-controlled liposomes containing curare-like drugs. ALYAUTDIN, R. N., FILIPPOV, V. I., and NEMIROVSKII, A. Yu., Farmatsiya (Moscow), 1989, 38, (3), 20–23.
  • Interleukin-2 liposomes for pulmonary metastases: local intrathoracic route and liposome formulation have superior anticancer effects. ANDERSON, P. M., LEONARD, A. S., NESBIT, M., and OCHOA, A. C., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 365.
  • Pharmacokinetics of intra-arterial mitomycin C with or without degradable starch micro-spheres (DSM) in the treatment of non-resectable liver cancer. ANDERSSON, M., ARONSEN, K. F., BALCH, C., DOMELLOF, L., EKSBORG, S., HAFSTROM, L. 0., HOWELL, S. B., KARESEN, R., MIDANDER, J., and TEDER, H., Acta Oncol., 1989, 28, (2), 219–222.
  • Injection of the cAMP-dependent protein kinase II regulatory subunit into 3T3 cells, using erythrocyte ghosts. APRIKYAN, A. G., ZHULEVA, L. Yu., NESTEROVA, M. V., and SEVERIN, E. S., Biokhimiya (Moscow), 1989, 54, (6), 980–986.
  • Preparation of polylactic acid-polylipoic acid nanospheres as drug targeting carriers. ARAI, K., TAKAYAMA, K., NAMBU, Y., NAMBU, N., UEDA, H., MACHIDA, Y., and NAGAI, T., Drug. Des. Deily., 1987, 2, (2), 109–120.
  • Interactions between aminoglycosides and phospholipids using liposomes: a possible mech-anism of nephrotoxicity. ARAMAKI, Y., and TSUCHIYA, S., Pharm. Res., 1989, 6, (5), 362–366.
  • In vitro release of gentamicin from beads, an original galenic form, and in vivo efficacy in abdornino-perineal surgery. ARMINOT DU CHATELET, A. M., FOURCADE, S., ATISSO, M. A., DE BOUCHBERG, M. S., YAKOUN, M., VARET, A., and PIEDRA, C., Pharmazie, 1989,44, (2), 131–132.
  • Aggregation of human plasma low density lipoproteins by means of poly (ethylene glycol). ARNOLD, K., and ZSCEIORNIG, 0., Biomed. Biochim. Acta, 1988, 47, (12), 949–954.
  • Biochemical and cellular effects of degraded starch microspheres on macrophages. ARTURSSON, P., BERG, A., and EDMAN, P., Int. J. Pharm., 1989, 52, (3), 183–190.
  • Physical and chemical processes in semipermeable nylon capsules. ARUNA, G., and SASTRI, N. V. S., Indian Chem. Eng., 1989, 31, (1), 50–54.
  • Antitumor activity of adriamycin bound to nanoparticles on two human cancer cell lines. ASTIER, A., BENOIT, G., DOAT, B., FERRER, M. J., and LEVERGE, R., INSERM (National Institute of Health and Medical Research). In vitro Methods in Pharmacotoxicology. M. ADOLPHE, and A. Gutu-ouzo (eds). (Les Editions INSERM: Paris, France), 1988, Vol. 170, p. 240.
  • Quantitating error in blood flow measurements with radioactive microspheres. AUSTIN, R. E. Ja, HAUCK, W. W., ALDEA, G. S., FLYNN, A. E., COGGINS, D. L., and HOFFMAN, J. I., Am. J. Physiol., 1989, 257, (1, Pt 2), H280–H288.
  • Liposomes as carriers for anti-inflammatory agents. AXELSSON, B., Adv. Drug Delivery Rev., 1989, 3, (3), 391–404.
  • Proton NMR study of the effects of complexons on the dynamic structure of lecithin vesicles. BABUSHKINA, T. A., Zh. Fiz. Klum., 1989, 63, (4), 1037–1041.
  • Niosomes: a putative drug carrier system. BAILLIE, A. J., NATO ASI Ser., Ser. A, 1988, 155, 143–151.
  • Development of a fully automated immunoassay for human luteinizing hormone on the Abbott IMX automated immunoassay system. BAKER, H. N., FORD, K. A., BAAR, J. G., BALAY, D., VENETUCCI, M., MARLEWSKI, D., and OGUNRO, E. A., Clin. Chem., 1989, 35, (6), 1203.
  • Host and donor erythrocyte repopulation patterns after allogeneic bone marrow transplan-tation analysed with antibody-coated fluorescent microspheres. BAR, B. M., SCHATTENBERG, A., VAN-DIJK, B. A., DE MAN, A. J., KUNST, V. A., and DE WITTE, T., Br. J. Haematol., 1989, 72, (2), 239–245.
  • The topography of acetylcholinesterase in dimyristoylphosphatidylcholine liposomes. BARBER, R. F., STUHNE SEKALEC, L., SHEK, P., N., and STANACEV, N. Z., J. Microencapstd., 1989, 6 (3), 301–309.
  • Chitosan immobilization and permeabilization of cultured Apium Graveolens, Chenopodium Rubrum and Daucus Carota cells. BEAUMONT, M., PANDYA, Y., and KNORR, D. Food Biotechnol. (NY), 1989, 3, (1), 71–88.
  • Characterization of halorhodopsin reconstituted in asolectin liposomes. BECKMANN, M., TITTOR, J., and OESTERHELT, D., Jerusalem Symp. Quantum Chem. Biochem., 1988, 21, 421–428.
  • Interaction of the fluoroquinolone antimicrobial agents ciprofloxacin and enoxacin with liposomes. BEDARD, J., and BRYAN, L. E., Antimicrob. Agents Chemother., 1989, 33, (8), 1379–1382.
  • Study of the penetration of polymethacrylate nanoparticles: potential drug vectors in primary cultures of rat and human hepatocytes and hepatoma cell lines. BEGUE, J. M., ROLLAND, A., MERDRIGNAC, G., LE VERGE, R., GUGUEN-GUILLOUZO, C., and GUILLOUZO, A. INSERM (National Institute of Health and Medical Research). In Vitro Methods in Pharmacotoxicology. M. ADOLPHE and A. Guii,Loozo (eds). (Les Editions INSERM: Paris, France), 1988, Vol. 170, p. 188.
  • The temporal sequence of events in the activation of phospholipase A2 by lipid vesicles. Studies with the monomeric enzyme from Agkistrodon piscivorus piscivorus. BELL, J. D., and Biltonen, R. L., J. Biol. Chem., 1989, 264, (21), 12194–12200.
  • Purification and characterization of UDP-gal: ceramide galactosyltransferase and reconsti-tution of its activity by incorporation into liposomes. BERARDI, A., FABRIZI, G. M., MANETTI, R., COSTANTINO C.-E.,NATO ASI Ser., Ser. A, 1988, 150, 681–687.
  • Ordering and patterning of interacting microparticles: confined repulsive particles and isotope correlations. BEREZIN, A.-A., GSI-Rep, 1989, 255–258.
  • Microencapsulation of emulsified oil droplets by in situ vinyl polymerization. BERG, J., SUNDBERG, D., and KRONBERG, B., J. Microencapsul., 1989, 6, (3), 327–337.
  • Correlation of partitioning of nitroimidazoles in the n-octanol/saline and liposome systems with pharmacokinetic parameters and quantitative structure-activity relationships (QSAR). BETAGERI, G. V., and ROGERS, J. A., Pharm. Res., 1989, 6, (5), 399–403.
  • Lipid-peptide interactions: phosphorus-31 nuclear magnetic resonance and differential scanning calorimetric study of staphylococcal delta-lysin and liposomes. BHAKOO, M., LEWIS, R. N. A. H., and MCELHANEY, R. N., Biochem. Soc. Trans., 1989, 17, (6), 1094–1095.
  • Indium(III) labeled liposome scans: a new approach to detecting occult metastatic disease. BHARDWAJ, S., SCHWARTZ, G. K., PALESTRO, C., GOLDSMITH, S. J., VALLABHAJOSULA, S., FLYNN, B. E., PREISS, S. J., and HOLLAND, J. F., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 233.
  • Dietary fat and menstrual-cycle effects on the erythrocyte ghost insulin receptor in pre-menopausal women. BHATHENA, S. J., BERLIN, E., Juno, J. T., JoNEs, J., KENNEDY, B. W., SMITH, P. M., JONES, D. Y., TAYLOR, P. R., CAMPBELL, W. S., BLANCHARD, S., et al., Am. J. Clin. Nutr., 1989, 50, (3), 460–464.
  • Photochemical energy conversion in lecithin liposomes in the presence of phenosafranin and chlorophyll. BHATTACHARYYA, M., BHOWMIH, B. B., and NANDY, P., Energy, 1989, 14, (6), 345–348.
  • Treatment of liver tumors with yttrium-90 microspheres alone. BLANCHARD, R. J., MORROW, I. M., and SUTHERLAND, J. B., Can. Assoc. Radiol. J., 1989, 40, (4), 206–210.
  • A novel approach to the oral delivery of micro- or nanoparticles. BODMEIER, R., CHEN, H. G., and PAERATSKUL, 0., Pharm. Res., 1989, 6, (5), 413–417.
  • Microencapsulated insecticidal pathogens. US Patent 4844896; July 4, 1989. Bonm, H. A., and FRIEND, D. R., Off. Gaz. US Pat. Trademark Off. Pat., 1989, 1104, (1), 437.
  • Phagocytosis of microspheric hydrophile particles by peripheral blood glass-adherent phago-cytes of healthy and high risk neonates. BORTE, M., MILER, I., and BRAUN, W., Acta. Paediatr. Hung., 1988-89, 29, (1–2), 197–202.
  • Freeze-drying as a method of preservation of erythrocyte ghosts. BREARLEY, C. A., HODGES, N. A., and OLLIFF, C. J., J. Pharm. Pharmacol., 1988, 40, (Suppl.), 132.
  • Removal of digoxin from the circulation using immobilized monoclonal antibodies. BRIZGYS, M. V., PINCUS, S., SIEBERT, C. J., and ROLLINS, D. E., J. Pharm. Sci., 1989, 78, (5), 393–398.
  • Stability and fusion of lipid vesicles containing headgroup-modified analogs of phospha-tidylethanolamine. BROWN, P. M., and Sitvius, J. R., Biochim. Biophys. Acta, 1989, 980, (2), 181–190.
  • Comparison of the translational diffusion of large spheres and high-molecular-weight coils in polymer solutions. BROWN, W., and RYMDEN, R., Macromolecules, 1988, 21, (3), 840–846.
  • Calcium(V)dependent interaction of small, negatively charged liposomes with large unilamellar phosphatidylcholine liposomes. BUDICER, V. G., KISELEVA, E. V., SEREBRYAKOVA, M. V., and SoxoLov, A. V., Dokl. Akad. Nauk, SSSR (Biophys.), 1989, 305, (6), 1495–1498.
  • Preparation, properties and therapeutic potential of cytidine diphosphocholine incorporated into liposomes. BURLINA, A. P., and GALZIGNA, L., Riv. Neurol., 1989, 59, (1), 26–31.
  • Influence of lipid characteristics on the encapsulation efficiency and stability of liposomes. BUSQUETS, M. A., CAJAL, Y., ALSINA, M. A., HARO, I., Rio, F., and GARC/A ANTON, J. M., Biochem. Soc. Trans., 1989, 17, (6), 1001–1002.
  • Doxorubicin, in cholesterylpolyoxyethylene modified niosomes: evidence of enhancement of absorption in mice. CABLE, C., CASSIDY, J., KAYE, S. B., and FLORENCE, A. T., J. Pharm. Pharmacol., 1988, 40, (Suppl.), 31.
  • Mixed polyglycerol polyoxyethylene ether niosomes. CABLE, C., and FLORENCE, A. T., J. Pharm. Pharmacol., 1988, 40, (Suppl.), 30.
  • The influence of polyunsaturated fatty acids on spermine inhibition of lipoperoxidation. Studies on liposomes prepared with microsomal and mitochondrial phospholipids of sea bass (Dicentrarchus labrax L.) and rat liver. CABRINI, L., TADOLINI, B., LANDI, L., FIORENTINI, D., and SECHI, A. M., Comp. Biochem. Physiol. (B), 1989, 93, (3), 647–651.
  • Fluorescence depolarization of cis- and trans-parinaric acids in artificial and red cell membranes resolved by a double hindered rotational model. CALAFUT, T. M., Dix, J. A., and VERKMAN, A. S., Biochemistry, 1989, 28, (12), 5051–5058.
  • Liposome-nucleus interactions. Flow cytometric study on the role of the nuclear surface. CARAMELLI, E., PAPA, S., BILLI, A. M., VITALE, M., BARTOLETTI, A., MANZOLI, L., and CAPITANI, S., Cell Biochem. Funct., 1989, 7, (1), 71.
  • Visceral leishmaniasis: drug carrier system characteristics and the ability to clear parasites from the liver, spleen and bone marrow in Leishmania donovani infected BALB/c mice. CARTER, K. C., DOLAN, T. F., ALEXANDER, J., BAILLIE, A. J., and MCCOLGAN, C., J. Pharm. Pharmacol., 1989, 41, (2), 87–91.
  • Depression of polymorphonuclear leukocyte functions by purified influenza virus hemag-glutinin and sialic acid-binding lectins. CASSIDY, L. F., LYLES, D. S., and ABRAMSON, J. S., J. Immunol., 1989, 142, (12), 4401–4406.
  • Encapsulation of the UV-DNA repair enzyme T4 endonuclease V in liposomes and delivery to human cells. CECCOLI, J., ROSALES, N., Tsim is, J., and YAROSH, D. B., J. Invest. Dermatol., 1989, 93, (2), 190–194.
  • Rapid assessment of liposomal stability in blood by an aqueous nitroxide spin label. CFIAN, H. C., MAGIN, R. L., SWARTZ, H. M. J. Biochem. Biophys. Methods, 1989, 18, (4), 271–276.
  • Bioactive molecules immobilized to liposome modified albumin-blended chitosan membranes-antithrombotic and permeability properties. CHANDY, T., and SHARMA, C. P., J. Colloid Interface Sc., 1989, 130, (2), 331–340.
  • Artificial cells in medical applications with emphasis on hemoperfusion in aluminium removal and cross-over control clinical trial of reduced time hemoperfusion-hemodialysis. CHANG, T. M., BARRE, P., LISTER, C., and KURU VILLA, S., Contrib. Nephrol., 1989, 70, 237–249.
  • Plasma/intestinal concentration patterns suggestive of entero-portal recirculation of amino acids: effects of oral administration of asparaginase, glutaminase and tyrosinase immobilized by microencapsulation in artificial cells. CHANG, T. M., and LISTER, C., Biomater. Artif. Cells Arti f. Organs, 1988-89, 16, (5), 915–926.
  • Artificial cells with ultrathin lipid-polymer or lipid-protein membranes. CHANG, T. M. S., Adv. Exp. Med. Biol., 1988, 238, 215–223.
  • Hybrid artificial cells for encapsulation and immobilization of cells, organelles and multi-enzyme systems. CHANG, T. M. S., INSERM (National Institute of Health and Medical Research). Hybrid Artificial Organs: Concepts and Development. C. BAQUEY and B. DUPUY (eds). (Les Editions INSERM: Paris, France), 1989, Vol. 177, pp. 239–246.
  • Blood substitutes and artificial red cells prepared from modified hemoglobin. CHANG, T. M. S. In Ellis Horwood Series in Biomedicine: Blood Substitutes: Preparation, Physiology and Medical Applications. K. C. LOWE (ed.) (Ellis Horwood Ltd.: Chichester, UK), 1989, pp. 87–93.
  • Medical applications of artificial cells in transfusion: phenylketonuria, essential amino acid production and liver support. CHANG, T. M. S. In Annals of the New York Academy of Sciences. H. W. BLANCH and A. M. KLIBANOV (eds.). (New York Academy of Sciences: New York, NY, USA), 1988, Vol. 542, pp. 507–514.
  • Surface catalytic effect of liposome formation on lecithin-iodine interaction. A kinetic study. CHATTERJEE, I., BHOWMIK, B. B., and HANDY, P., Langmuir, 1989, 5, (4), 1035–1037.
  • Influence of polyisobutylene on microencapsulation of metronidazole. CHEMTOB, C., GRUBER, T., and CHAUMEIL, J. C., Drug Dev. Ind. Pharm., 1989, 15, (8), 1161–1174.
  • Superoxide dismutase in liposomes and its clinical use. CHEN YUTING and ZHENG RONGLIANG. Shengwu Huaxue Yu Shengwu Wuli Jinzhan, 1989, 16, (1), 23–26.
  • Electrostimulated DNA capture by liposomes. CHERNOMORDIK, L. V., SOKOLOV, A. V., and BUDKER, V. G., Biol. Membr., 1989, 6, (2), 212–217.
  • Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases. CHIANNILKULCHAI, N., DRIOUICH, Z., BENOIT, J. P., PARODI, A. L., and COUVREUR, P., Set. Cancer Ther., 1989,5, (1), 1–11.
  • Modification of gelatin beadlets for zero-order sustained release. CHIAO, C. S. L., and PRICE, J. C., Pharm. Res., 1989, 6, (6), 517–520.
  • Myocardial microcirculation based on scintigraphy with labeled microspheres. CHORGOLIANI, T. N., GRATSIANSKII, N. A., BUDANITSKII, V. A., KULIKOV, A. M., and, ZVENTOV, A. Z., Med. Radio., 1989, 34, (2), 3–8.
  • Changes in vascularity of liver tumours after hepatic arterial embolization with degradable starch microspheres. CIVALLERI, D., SCOPINARO, G., BALLETTO, N., CLAUDIANI, F., DECIAN, F., CAMERINI, G., DEPAOLI, M., and BONALUMI, U., Br. J. Surg., 1989, 76, (7), 699–703.
  • Effects of microgravity on liposome-reconstituted cardiac gap junction channeling activity. CLAASEN, D. E., and SPOONER, B. S., Biochem. Biophys. Res. Commun., 1989, 161, (1), 358–362.
  • Actin polymerization induces a shape change in actin-containing vesicles. CORTESE, J. D., SCHWAB, B. D., FRIEDEN, C., and ELSON, E. L., Proc. Natl. Acad. Sci. USA, 1989, 86, (15), 5773–5777.
  • The use of nano-particles for the vectorization of antibiotic and antineoplastic drugs. COUVREUR, P., FATTAL, E., ANDREMONT, A., CHIANNILKULCHAI, N., and BENOIT, J. P., Bull. Mem. Acad. R. Med. Belg., 1988, 143, (7-9), 378–388.
  • Functional reconstitution of photosynthetic cyclic electron transfer in liposomes. CRIELAARD, W., GABELLINI, N., HELLINGWERF, K. J., and KONINGS, W. N., Biochim. Biophys. Acta, 1989, 974, (2), 211–218.
  • Generating and loading of liposomal systems for drug-delivery applications. CuLLIs, P. R., MAYER, L. D., BALLY, M. B., MADDEN, T. D., and HOPE, M. J., Adv. Drug Delivery Rev., 1989,3, (3), 267–282.
  • Antitumor activity and fate of doxorubicin and 4'-deoxydoxorubicin-loaded protein microspheres in rats bearing a mammary carcinoma after intra-tumoral injection. CUMMINGS, J., WILLMOTT, N., MARLEY, E., and SMYTH, J., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 603.
  • Reconstitution and characterization of the human neutrophil N-formyl peptide receptor and GTP binding proteins in phospholipid vesicles. CUPO, J. F., ALLEN, R. A., JESAITIS, A. J., and Boxocu, G. M., Biochim. Biophys. Acta, 1989, 982, (1), 31–40.
  • Electrochemical aspects of the neutrophil response to surface-modified polystyrene microspheres. CUTTITTA, J. D., MARLOW, B. D., and DEBARI, V. A., Bioelectrochem. Bioenerg., 1989, 21, (1), 63–69.
  • Liposome-encapsulated-amikacin therapy of Mycobacterium aviurn complex infection in beige mice. CYNAMON, M. H., SWENSON, C. E., PALMER, G. S., and GINSBERG, R. S. Antimicrob. Agents Chemother., 1989, 33, (8), 1179–1183.
  • Fluorescence quenching with lindane in small unilamellar L-alpha-dimyristoyl-phosphatidylcholine vesicles. DAEMS, D., BOENS, N., and DE SCHRYVER, F. C., Eur. Biophys. J., 1989, 17, (1), 25–36.
  • Enhanced oxidation of bilirubin by an immobilized tri-enzyme system of glucose oxidase bilirubin oxidase and horseradish peroxidase. DAKA, N. J., SIPEHIA, R., and CHANG, T. M. S., Biochim. Biophys. Acta, 1989, 991, (3), 487–490.
  • Inhibition of phytohemagglutinine-induced T lymphocyte proliferation by 6-(octadecyldithio)purine, a novel liposomal prodrug of 6-mercaptopurine. DANIEL, P. T., HoLzscuun, J., MULLER, C. E., ROTH, H. J., and BERG, P. A., Arch. Toxicol. Suppl., 1989, 13, 179–182.
  • Stability of liposomes composed of polymerizable and/or natural phospholipids. DAVIES, D. E., GRAINGER, D., RINGSDORF, H., and LLOYD, J. B., Biochem. Soc. Trans., 1989, 17, (4), 713–714.
  • Microspheres as drug carriers. DAVIS, S. S., and ILLum, L., Horiz. Biochem. Biophys., 1989, 9, 131–153.
  • Association of synthetic model peptides with phospholipid vesicles induced by a membrane potential. DE KROON, A. I. P. M., DE GIER, J., and DE KRUIJFF, B., Biochim. Biophys. Acta, 1989, 981, (2), 371–373.
  • Preparation and characterization of lactic/glycolic acid polymers and copolymers. DEASY, P. B. FINAN, M. P., and MEEGAN, M. J., J. Microencapsul., 1989, 6, (3), 369–378.
  • Liposome-associated tumor necrosis factor retains bioactivity in the presence of neutralizing anti-tumor necrosis factor antibodies. DEBS, R. J., DUZGUNECS, N., BRUNETTE, E. N., FENDLY, B., PATTON, J., PHILIP, R., J. Immunol., 1989, 143, (4), 1192–1197.
  • Pharmacolinetics of imidocarb dipropionate encapsulated in carrier erythrocytes and use of carrier cells for babesiosis chemotherapy. DELOACH, J. R., WAGNER, G. G., and CORRIER, D. E., J. Controlled Release, 1989, 9, (3), 243–248.
  • Comparison of gas clearance and radioactive microspheres for pancreatic blood flow measurement. DEMAR, A. R., GRAHAM, L. S., LAKE, R., and FINK, A. S., Pancreas, 1989,4, (2), 161–168.
  • Interaction of immunoliposomes with avian myeloblastosis virus and virus transformed cells. DHANANJAYA, K. V., and ANTONY, A. Indian. J. Exp. Biol., 1988, 26, (12), 965–968.
  • Transplanted microencapsulated hepatocytes in glucuronyltransferase deficient rats can reduce hyperbilirubinemia. DIXIT, V., STALNIKOWICZ, R., ARTHUR, M., BREZINA, M., and GITNICK, G., Gastroenterology, 1989, 96, (5, Part 2), A594.
  • Importance of the purification grade of 5(6)-carboxyfluorescein on the stability and permea-bility properties of N-acyl-phosphatidylethanolamine liposomes. DOMINGO, J. C., ROSELL, F., MORA, M., and DE MADARIAGA, M. A., Biochem. Soc. Trans., 1989, 17, (6), 997–999.
  • Granulomatous hypersensitivity to Schistosoma mansoni egg antigens in human schisto-somiasis. I. Granuloma formation and modulation around polyacrylamide antigen-conjugated beads. DOUGHTY, B. L., GOES, A. M., PARRA, J. C., ROCHA, R. S., KATZ, N., COLLEY, D. G., and GAZZINELLI, G., Mem. Inst. Oswald°. Cruz., 1987, 82, (Suppl. 4), 47–54.
  • IMX AFP, an automated microparticle immunoassay for alpha fetoprotein performance characteristics and clinical studies. DOWELL, B., BORDEN, K., and SFIAW, N. Clin. Chem., 1989, 35, (6), 1192.
  • Preparation of poly(methacrylic acid-g-ethylene oxide) microspheres. DRUMMOND, R. K., KLIER, J., ALAMEDA, J. A., and PEPPAS, N. A., Macromolecules, 1989, 22, (9), 3816–3818.
  • Impermeability of polyacrylamide microcapsules to antibodies. DUPUY, B., GIN, H., CAIX, J., BAQUEY, C., and DUCASSOU, D., INSERM (National Institute of Health and Medical Research). Hybrid Artificial Organs: Concepts and Development. C. BAQUEY and B. DUPUY (Eds.). (Les Editions INSERM: Paris, France), 1989, Vol. 177, pp. 221–230.
  • A comparative therapeutic study of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes in human breast ovarian and colon tumors. DUSRE, L., FORST, D., and RAHMAN, A., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 556.
  • Biophysical aspects of lipid interaction with mineral: liposome model studies. EANES, E. D., Anat. Rec., 1989, 224, (2), 220–225.
  • Intervesicular exchange of lipids with weak acid and weak base characteristics: influence of transmembrane pH gradients. EASTMAN, S. J., WILSCHUT, J., Cum.'s, P. R., and HOPE, M. J., Biochim. Biophys. Acta, 1989, 981, (2), 178–184.
  • Mass transfer effects in microencapsulated hybridoma cells producing monoclonal anti-bodies. EDMUNDS, W. W., KARGI, F., and SORENSON, C., Appl. Biochem. Biotechnol., 1989, 20–21. 603–619.
  • The effect of liposome encapsulated antineoplastic agents on transitional cell carcinoma in tissue culture. EGERDIE, R. B., REID, G., and TRACHTENBERG, J., J. Urol., 1989, 142, (2), 390-398. Preparation and evaluation of some slow-release iron formulations. EL-Stusixt, H. A., ABDEL- GHANI, Y. M., and NADA, A. H., Alexandria J. Pharm. Sci., 1989, 3, (1), 56–62.
  • Microencapsulated enzyme systems for the acceleration of cheese ripening. EL-SODA, M., PANNELL, L., and OLSON, N., J. Microencapsul., 1989, 6, (3), 319–326.
  • Studies on the mechanism of action of a bilayer stabilizing inhibitor of protein kinase C: cholesterylphosphoryldimethylethanolarnine. EPAND, R. M., STAFFORD, A. R., BOTTEGA, R., and BALL, E. H., Biosci. Rep., 1989, 9, (3), 315–328.
  • Adsorption of some solutes on heat-treated meso-carbon microbeads treated by plasma. Esuml, K., KIMURA, Y., NAKADA, T., MEGURAO, K., HONDA, H., Carbon, 1989, 27, (2), 301–303.
  • Quasi-elastic and electrophoretic light scattering studies of phospholipid vesicle reorganiz-ation in the presence of a poly(acrylic acid) derivative. Eum, K1 MIN, University of Massachusetts, Amherst, MA, USA, Dissertation, 1988, 143 pp.
  • Reversal of tumor cell resistance to adriamycin by presentation of the drug incorporated in liposomes. FAN, D., SEID, C., BUCANA, C. D., FIDLER, I. J., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 522.
  • Liposome-encapsulated hemoglobin: a synthetic red cell. FARMER, M. C., JOHNSON, S. A., BEISSINGER, R. L., GOSSAGE, J. L., LYNN, A. B., and CARTER, K. A., Adv. Exp. Med. Biol., 1988, 238, 170.
  • Evidence from ESR studies for virtual immobility in niosomes derived from steroidal lariat ethers. FASOLI, H., ECHEGOYEN, L. E., HERNANDEZ, J. C., GOKEL, G. W., and ECHEGOYEN, L., J. Chem. Soc. Chem. Commun., 1989, (9), 578–580.
  • Distribution of liposome-entrapped spin label after liver blockade with empty liposomes. FEDERICO, M., CHAN, H. C., IANNONE, A., and MAGIN, R. L., Proc. Am. Assoc. Cancer. Res. A717114. Meet., 1989, 30, 602.
  • Bone marrow uptake of liposome-entrapped spin label after liver blockade with empty liposomes. FEDERICO, M., IANNONE, A. CHAN, H. C., and MAGIN, R. L., Magn. Reson. Med., 1989, 10, (3), 418–425.
  • Spin trapping of lipid-derived radicals in liposomes. FEIX, J. B., and KALYANARAMAN, B., Biochim. Biophys. Acta, 1989, 992, (2), 230–235.
  • Cationic liposome mediated transfection. FELGNER, P. L., HOLM, M., and CHAN, H., Proc. West Pharmacol. Soc., 1989, 32, 115–121.
  • Interactions and reactions in polymerized vesicles. FENDLER, J. H., Report, 1988 (ARO-23034.11-CH; Order No. AD-A201527), 6 pp.
  • The use of liposomes as drug carriers in the immunotherapy of cancer. FIDLER, I. J., Horiz. Biochem. Biophys., 1989, 9, 213–248.
  • The use of inhaled liposome formulations for drug delivery to the lungs and systemic circulation. FIELDING, R. M., Proc. West. Pharmacol. Soc., 1989, 32, 103–106.
  • Chemotherapy of solid tumors in vivo using site directed daunorubicin liposomes. FORSSEN, E. A., COULTER, D. M., PRESANT, C. A., and PROFFITT, R. T., Proc. Am. Assoc. Cancer Res. Annu. Meet, 1989, 30, 604.
  • Nuclear magnetic resonance spectroscopic studies of interaction of bis-GMA analogues with phosphatidylcholine liposomes as a model for biomembranes. FupsAwA, S., KADOMA, Y., and KOMODA, Y., Biomaterials, 1989, 10, (4), 269–272.
  • Encapsulation of doxorubicin in stable liposomes with long circulation times in mice: changes in pharmacokinetics and tissue distribution. GABIZON, A., and PAPAHADJOPOULOS, D., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 605.
  • Liposomes as a drug delivery system in cancer chemotherapy. GABIZON, A., Horiz. Biochem. Biophys., 1989,9, 185–211.
  • Liposome encapsulation facilitates enhanced killing effect of amikacin on Myocabacterium-avium complex (MAC) in beige mice and macrophages. GANGADHARAM, P. R. J., KESAVALU, J., GOLDSTEIN, J., DEBS, R. J., and DUZGUNNES, N., V International Conference on AIDS: the Scientific and Social Challenge: Montreal, Quebec, Canada, 4–9 June, 1989. R. A. MORISSET (ed.). (International Development Research Centre: Ottawa, Ontario, Canada), publ. 1989, p. 253.
  • Liposomes of enviroxime and phosphatidylcholine: definition of the drug-phospholipid interactions. GARCON, N. M., Svc, H. R., FRAZER, J., HAZLEWOOD, C., GILBERT, B. E., and KNIGHT, V. Antiviral Res., 1989, 11, (2), 89–98.
  • Intermixing of dipalmitoylphasphaditylcholine with phospho- and sphingolipids bearing highly asymmetric hydrocarbon chains. GARDAM, M., and SILvius, J. R., Biochim. Biophys. Acta, 1989, 980, (3), 319–325.
  • Purification and reconstitution into liposomes of an integral membrane protein conferring immunity to colicin A. GELI, V., KNIBIEHLER, M., BERNADAC, A., and LAZDUNSKI, C., FEMS Microbiol. Lett., 1989, 60, (2), 239–243.
  • Identification of phospholipid-dependent calcium-binding proteins as constituents of matrix vesicles. GENGE, B. R., Wu, L. N.Y., and WUTHIER, R. E., J. Biol. Chem., 1989, 264, (18), 10917–10921.
  • Treatment of hepatic malignancy with liposome-entrapped doxorubicin. GILMORE, I. T., SELLS, R. A., OWEN, R. R., NEW, R. R. C., and STRINGER, R. E., Gastroenterology, 1989, 96, (5, Part 2), A601.
  • Topo-optical studies of gradually disintegrated erythrocyte membrane derivates different kinds of ghosts. GLIESING, M., and HALBHUBER, K. J., Acta Histochem, 1989, 86, (2), 117–122.
  • Effect of diacylglycerols on calcium-induced fusion of phosphatidylserine/phosphatidyl-choline vesicles. GOMEZ, F. J. C., ARANDA, F. J., MICOL, V., VILLALAIN, J., and ORTIZ, A., Biochem. Soc. Trans., 1989, 17, (6), 957–960.
  • Surfactant-induced liposome fusion: molecular mechanisms and biotechnological appli-cations. GONI, F. M., and ALONSO, A., Adv. Exp. Med. Biol., 1989, 238, 81–103.
  • Inhibition of the pituitary-gonadal axis by a single intramuscular administration of P-Trp-6-LH-RH (decapeptyl) in a sustained-release formulation in patients with prostatic carcinoma. GONZALEZ-BARCENA, D., PEREZ-SANCHEZ, P. L., GRASP, A., GOMEZ, A. M., BEREA, H., COMARU-SCHALLY, A. M., and SCHALLY, A. V., Prostate, 1989, 14, (4), 291–300.
  • Liposomes prepared from synthetic amphiphiles. I. Their technetium labeling and stability. GOTO, R., KUBO, H., and OKADA, S., Chem. Pharm. Bull., 1989, 37, (5), 1351–1354.
  • Detection of a novel binding site for butanol in DPPC/GM1 liposomes by deuterium NMR spectroscopy. GRAHAM-BRITTAIN, C., HITZEMANN, R. J., and KREISHMAN, G. P., Prog. Clin. Biol. Res., 1989, 292, 23–31.
  • Physical biochemistry of a liposomal amphotericin B mixture used for patient treatment. GRANT, C. W., HAMILTON, K. S., HAMILTON, K. D., and BARBER, K. R., Biochim. Biophys. Acta, 1989, 984, (1), 11–20.
  • A liposomal MRI Contrast Agent, Phosphatidylethanolamine DTPA. GRANT, C. W. M., KARLIK, S., and FLORIO, E., Magn. Reson. Med., 1989, 11, (2), 236–243.
  • Follicle stimulating hormone (FSH) induces G protein dissociation from FSH receptor-G protein complexes in reconstituted proteoliposomes. GRASSO, P., and REICHERT, L. E. Jr., Biochetn. Biophys. Res. Commun., 1989, 162, (3), 1214–1221.
  • Enhanced fluorescence in indirect immunophenotyping by the use of fluorescent liposomes. GRAY, A. G., MORGAN, J., LINCH, D. C., and HUEHNS, E. R., J. Immunol. Methods, 1989, 121,(1), 1–7.
  • Liposomes as a drug delivery system: optimization studies. GREGORIADIS, G., Adv. Exp. Med. Biol., 1988, 238, 151–159.
  • Liposomes as carriers of drugs. Observations on vesicle fate after injection and its control. GREGORIADIS, G., Subcell. Biochem., 1989, 14, 363–378.
  • The immunoadjuvant action of liposomes: optimization studies. GREGORIADIS, G., DAVIS, D., and GARCON, N., NATO ASI Ser., Ser. A, 1988, 155, 153–165.
  • The partition and distribution of porphyrins in liposomal membranes. A spectroscopic study. GROSS, E., and EHRENBERG, B., Biochim. Biophys. Acta, 1989, 983, (1), 118–122.
  • Liposomal formulation eliminates acute toxicity and pump incompatibility of parenteral cyclosporine. GRUBER, S. A., VENKATARAM, S., CANAFAX, D. M., CIPOLLE, R. J., BOWERS, L., ELSBERRY, D., McGuloomi, M., HYNES, P. E., RITZ, J. A., et al., Pharm. Res., 1989, 6, (7), 601–607.
  • Characterization of changes in the activity of 10 -n-nitrophenylphosphatase of erythrocyte ghosts under the influence of ouabain. GULIDOVA, G. P., and CHEKRYGINA, 0. N., Ukr. Biokhim. Zh., 1989, 61, (1), 82–85.
  • Liquid-coacervate extraction. GULLICKSON, N. D., SCHAMEHORN, J. F., and HARWELL, J. H., Surfactant Sci. Ser., 1989, 33, 139–152.
  • Glucose-6-phosphate phosphohydrolase activity in guinea-pig liver microsomes is influenced by phosphatidylcholine interaction with cholesterol-enriched membranes. GUMBHIR, K., SANYAL, S. A., MINOCHA, R., WALI, A., and MAJUMDER, S., Biochim. Biophys. Acta, 1989, 981, (1), 77–84.
  • Liposomes with enhanced retention on mucosal tissue. US patent 4839175; June 13, 1989. Guo, L. S. S., REDEMANN, C. T., RADHAKRISHNAN, R., and YAU YOUNG, A., Off. Gaz. US Pat. Trademark Off. Pat., 1989, 1103, (2), 1202.
  • Artificial liposomes as a model for studying the lipid peroxidation effect of p-phenylenediamine. GUPTA, V., MISRA, V., and VISWANATHAN, P. N., J Microencapsul., 1989,6, (3), 311–318.
  • Evaluation of indomethacin nanocapsules for their physical stability and inhibitory activity on inflammation and platelet aggregation. GURSOY, A., EROGLU, L., ULUTIN, S., TASYUREK, M., FESSI, H., PUISIEUX, F., and DEVISSAGUET, J. P., Int. J. Pharm., 1989, 52, (2), 101–108.
  • Effect of human plasma on the stability of large multilamellar liposomes with digitoxin. GUZMAN, M., SELLES, E., and ABERTURAS, M. R., Drug Dev. Ind. Pharm., 1989, 15, (11), 1759–1770.
  • Sensitivity improvement of full color system by blending nonsilver and silver microcapsules. GYURE, K. A., and TRUINI, J. G., Res. Discl., 1989, 301, 359.
  • Liposome compostion. US Patent 4844904; July 4, 1989. HAMAGUCHI, N., IcA, K., and OGAWA, Y., Off. Gaz. US Pat. Trademark Off. Pat., 1989, 1104, (1), 440.
  • Improved adhesion of microcapsules to a substrate using ultraviolet-sensitive crosslinkers. HAMMANN, B., and GOTTSCHALK, P., Res. Disci., 1989, 301, 385–386.
  • Treatment of infectious diseases with liposome-encapsulated antibiotics. HARA, K., KOHNO, S., and MIYAZAKI, T., Nippon-Rinsho, 1989, 47, (6), 1288–1294.
  • Staphylococcal alpha-toxin: a study of membrane penetration and pore formation. HARSHMAN, S., BOQUET, P., DUFLOT, E., ALOUF, J. E., MONTECUCCO, C., and PAPIN, E., J. Biol. Chem., 1989, 264, (25), 14978–14984.
  • Approaches to artificial red cell and artificial blood. HASEGAWA, E., and TSUCHIDA, E., Kobunshi, 1989, 38, (7), 728–731.
  • Effect of vitamin E-containing liposome on experimental sugar cataract. HATTORI, H., MAJIma, Y., NAGAMURA, Y., and IsHIGURO, I., Nippon Ganka Gakkai Zasshi, 1989,93, (1), 97-102. Mechanism of spontaneous vesiculation. HAUSER, H., Proc. Nail Acad. Sci. USA, 1989, 86, (14), 5351–5355.
  • Stabilization of small, unilamellar phospholipid vesicles by sucrose during freezing and dehydration. HAUSER, H., and STRAUSS, G., Adv. Exp. Med. Biol., 1988, 238, 71–80.
  • Tissue distribution of indium(III)-labeled poly(glycolic acid) matrixes following jugular and hepatic portal vein administration. HAZRATI, A. M., AKRAWI, S., HICKEY, A. J., WEDLUND, P., MACDONALD, J., and DELucA, P. P., J. Controlled Release, 1989, 9, (3), 205–214.
  • Anti-tac and anti-transferrin-targeted liposomes are effective for specific drug delivery to adult T cell leukemia. HEGE, K., DALEKE, D., WALDMANN, T. A., and MATTHAY, K. K., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 391.
  • A rapid HIV antibody test using liposome-based technology. HILBERG, C., BLACKWELL, J., DUSCHL, D., BRITS, J., Abstr. Annu. Meet. Am. Soc. Microbiol, 1989, 89, 383.
  • A rapid whole blood application for HIV antibody testing using liposome-based technology. HILBERG, C., DUSCHI, D., BLACKWELL, J., HUFF, J., BRITZ, J., and SMIALEK, J., V International Conference on AIDS: the Scientific and Social Challenge; Montreal, Quebec, Canada, 4–9 June, 1989. (International Development Research Centre: Ottawa, Ontario, Canada), R. A. MORISSET (ed.). publ. 1989, p. 191.
  • IV injection of air-filled human albumin microspheres to enhance arterial Doppler signal: a preliminary study in rabbits. HILPERT, P. L., MATTREY, R. F., MITTEN, R. M., and PETERSON, T., AJR Am. J. Roentgenol., 1989, 153, (3), 613–616.
  • Cytotoxicity to a tumor cell line of epoxy-phosphatidylinositol liposomes. HIRASAWA, K., SATO, Y., YAMAMOTO, S., FUKUDA, Y., and MIN°, M., J. Liposome Res., 1989, 1, (2), 223–232.
  • Effects of non-electrolyte molecules with anesthetic activity on the physical properties of DMPC multilamellar liposomes. HITZEMANN, R. J., Biochim. Biophys. Acta, 1989, 983, (2), 205–211.
  • Antigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs. Ho, R. J. Y., BURKE, R. L., and MERIGAN, T. C., J. Virol., 1989,63, (7), 2951–2958.
  • Induction of stable chimerism and elimination of graft-versus-host disease by depletion of T lymphocytes from bone marrow using immunomagnetic beads. HOFFMAN, A. L., MAKOWKA, L., CRAMER, D. V., CAI, X., BANNER, B., PASCUALONE, A., HOFFMANN, S., and STARZL, T. E., Surgery, 1989, 106, (2), 354–363.
  • Gold labeling of cell monolayers grown on dextran beads. HOGAN, M. E., HASSOUNA, H. I., and KLOMPARENS, K. L., Am. J. Anat., 1989, 185, (2-3), 296–300.
  • Size distribution of rhodamine-labelled microspheres retrogradely transported in cultured neurons. HOLLANDER, H., EGENSPERGER, R., and DIRLICH, G., J. Neurosci. Methods, 1989,29, (1), 1–4.
  • Therapy of central nervous system leukemia in mice by liposome-entrapped 1-beta-o-arabinofuranosylcytosine. HONG, F., and MAYHEW, E., Cancer. Res., 1989,49, (18), 5097–5102.
  • Phospholipid asymmetry in large unilamellar vesicles induced by transmembrane pH gradients. HOPE, M. J., REDELMEIR, T. E., WONG, K. F., RODRIGUEZA, W., and CULLIS, P. R., Biochemistry, 1989, 28, (10), 4181–4187.
  • Homogeneous immunoassay for alpha 2 plasmin inhibitor (alpha 2PI) and alpha 2P1-plasmin complex. Application of a sandwich liposome immune lysis assay (LILA) technique. HOSODA, K., and YASUDA, T., J. Immunol. Methods, 1989, 121, (1), 121–128.
  • Surface charged liposomes as drug carriers and in vivo tests of mice infected with toxoplasma. Hou, X. P., TAO, F., Yi, Y. Y., and WANG, W. L., Acta Pharm. Sin., 1989, 24, (1), 53–57.
  • Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. HOULE, S., YIP, T. K., SHEPHERD, F. A., ROTSTEIN, L. E., SNIDERMAN, K. W., THEIS, E., CAWTHORN, R. H., and RICHMOND-Cox, K., Radiology, 1989, 172, (3), 857–860.
  • Preparation of solid core liposomes. US Patent 4839111; June 13, 1989. HUANG, L., Off. Gaz. US Pat. Trademark Off. Pat., 1989, 1103, (2), 1185.
  • Liposome-mediated transformation. HUGHES, K. W., ZHEN, Z., and HUANG, L., J. Cell. Biochem. Suppl., 1989 (13, Part D), 260.
  • Liposome-mediated transformation of tobacco protoplasts. HUGHES, K. W., ZHEN, Z., HUANG, L., and CONTOLINI, C., Am. J. Bat., 1989, 76 (6, Suppl.), 148.
  • A comparative study of niosomes (nonionic surfactant vesicles) and liposomes: their stability in biological environments. HUME, L. R., University of Strathclyde, Glasgow, UK, Disser-tation, 1987, 184 pp.
  • The effect of n-alcohols on vesicular permeability induced at the lipid phase transition temperature: a proton NMR study. HUNT, G. R. A., and KASZUBA, M., Chem. Phys. Lipids, 1989, 51, (1), 55–65.
  • Transcatheter arterial chemoembolization therapy for hepatocellular carcinoma using polylactic acid microspheres containing aclarubicin hydrochloride. ICHIHARA, T., SAKAMOTO, K., MORI, K., and AKAGI, M., Cancer Res., 1989, 49, (15), 4357–4362.
  • Antitumor effect and indication of chemoembolization using degradable starch microspheres and regional hyperthermia in patients with hepatocellular carcinoma. ICHIKAWA, H., YOSHIKAWA, T., OYAMADA, H., NAITO, Y., UEDA, S.,TAINAKA, K., ITANI, K., SETO, 0., SUGINO, S., and RONDO, M., Gastroenterology, 96, (5, Part 2), A610.
  • Adrenal cytochrome P-45011 beta-proteolipsomes catalyzing aldosterone syntheis: prepar-ation and characterization. licustuRo, S., KOMINAMI, S., and TAKEMORI, S., Biochim. Biophys. Acta, 1989, 984, (1), 50–56.
  • The influence of pentacine encapsulated in liposomes on plutonium-239 excretion. IC ix, L. A., IVANNIKOV, A. T., ALTUKHOVA, G. A., PARFENOVA, I. M., and CHELYSHEVA, T. V., Radiobiologiya, 1989, 29, (2), 197–201.
  • Pharmaceutical composition including sodium cromoglycate. US Patent 4847091; July 11, 1989. ILLUM, L., Off. Gaz. US Pat. Trademark Off. Pat., 1989, 1104, (2), 1201.
  • Targeting of microspheres to sites of inflammation. ILLust, L., WRIGHT, J., and DAVIS, S. S., Int. J. Pharm., 1989, 52, (3), 221–224.
  • Rifampicin microspheres: formulation and in vitro release characteristics. ISERI, E., KAS, H. S., and HINCAL, A. A., Chim. Oggi, 1989, 7, (4), 15–16.
  • Enhanced immunogenicity of influenza virus hemagglutiinin when incorporated into lipo-somes. ISHBAEVA, R. I., GULIAKO, A. A., SIMONOV, A. N., KLEPPISH, I., and MAKHOV, A. M., Vopr. Virusol, 1989, 34, (2), 237–240.
  • Effect of copper-microencapsulation on the oxidation of hydrogen absorbing LaNi5-based alloys. Isim, E., OGURO, K., Suzusi, H., and MIYAMURA, H., Osaka Kogyo Gijutsu Shikenshi Kiho, 1989, 40, (1), 23–27.
  • Technology for preparation of liposome. Ism', F., and IsiticAmi, Y., Fragrance J., 1989, 17, (4), 78–81.
  • Effects of phosphatidylcholines containing furan fatty acid on oxidation in multilamellar liposomes. Isuii, K., OKAJIMA, H., OKADA, Y., and WATANABE, H., Chem. Pharm. Bull., 1989,37, (5), 1396–1398.
  • Stable liposomes for microcapsule immunoassay (MCIA) in human sera. ISHIMORI, Y., KOYAMA, M., ROKUGAWA, K., MOTODA, S., and MATSUDA, H., Clin. Chem., 1989, 35, (6), 1204.
  • Application of encapsulated enzyme as a continuous packed-bed reactor. Iso, M., SHIRAHASE, T., HANAMURA, S., URUSFIIYAMA, S., and Omi, S., J. Microencapsul., 1989, 6, (3), 285–299.
  • Efficacy of the fenitrothion microcapsule against termites coptotermes formosanus shiraki isoptera rhinotermitidae II. Transmissibility of renitrothion through grooming. IWATA, R., ITo, T., and SHThrio, G., Appl. Entomol. Zool., 1989, 24, (2), 213–221.
  • Conformational change of band 3 protein induced by diethyl pyrocarbonate modification in human erythrocyte ghosts. IZUHARU, K., OKUBO, K., and HAMASAKI, N., Biochemistry, 1989, 28, (11), 4725–4728.
  • Evaluation of microencapsulated antibiotics for the prevention and treatment of experimental osteomyelitis. JACOB, E., SETTERSTROM, J. A., BACH, D. E., McNtEsH, L. M., HEATH, J. R. III. Abstr. Annu. Meet. Am. Soc. Microbiol, 1989, 89, 8.
  • Hypothalamic phospholipid liposomes for the management of the climateric syndrome in obese women: hormonal and behavioral changes. JACOBELL, I. A., SIMEON, A., AGOSTINO, A., VECCI, E., and MARCHIONNE, A. M., Aliment. Nutr. Metal'., 1989, 10, (1), 9–16.
  • Competitive inhibition of phospholipase A2 in vesicles. JAIN, M. K., YUAN, W., and GELB, M. H., Biochemistry, 1989, 28, (10), 41354139.
  • Liposome biodistribution in the rabbit: influence of vesicle size and poloxamer coating. JAMSHAID, M., FARR, S. J., KEARNEY, P., and KELLAWAY, I. W., J. Pharm. Pharmacol., 1988, 40, (Suppl.), 135 P.
  • Non-specific cell binding characteristics of para-magnetic polystyrene microspheres used for antibody-mediated cell selection. JANSSEN, W. E., and Rios, A. M., J. Immunol. Methods, 1989, 121, (2), 289–294.
  • Microencapsulation of activable radiotherapeutic agents. JAY, M., KHARE, S. S., MUMPER, R. J.,, and RYO, U. Y. In Progress in Clinical and Biological Research, D. A. BUTTERFIELD (ed.) (A. R. Liss: New York, N.Y., USA), 1989, Vol. 292, pp. 293–300.
  • Activation of holmium-165 in biodegradable microspheres for therapy. JAY, M., MUMPER, R. J., KHARE, S. S., and RYO, U. Y., J. Nucl. Med., 1989, 30, (5 Suppl.), 836.
  • Muscarinic cholinergic receptors are affected by furion of phosphatidylserine liposomes with synaptosomal membranes. JERUSALINSKY, D., RIVAS, E., BERNIK, D., MEDINA, J., and DE ROBERTISE, E., J. Neurochem., 1989, 52, (Suppl.), S67.
  • Characterization of diphtheria toxin-induced lesions in liposomal membranes. An evaluation of the relationship between toxin insertion and "channel" formation. JIANG, G. S., SoLow, R., and Hu, V. W., J. Biol. Chem., 1989, 264, (23), 13424–13429.
  • A comparison of wax matrix and microencapsulated potassium chloride in relation to upper gastrointestinal illness requiring hospitalization. JIGK, H., ilex, S. S., WALKER, A. M., and STERGACHIS, A., Pharmacotherapy, 1989, 9, (4), 204–206.
  • Encapsulation of drugs by lyophilized, empty dipalmitoylphosphatidylcholine liposomes. Jizomom, H., KANAOKA, E., and HIRANO, K., Chem. Pharm. Bull, 1989, 37, (7), 1895–1898. Cells from Rana pipiens gastrulae and arrested hybrid gastrulae show differences in adhesion to fibronectin-sepharose beads. J. Exp. Zool., 1989, 251, (2), 155–166.
  • Enhanced in vivo activity of adriamycin incorporated into controlled release microspheres. JONES, C., BURTON, M. A., and GRAY, B. N., Br. J. Cancer, 1989, 59, (5), 743–745.
  • Interaction of nonsteroidal anti-inflammatory agents on monolayers: an approach for understanding the entrapment of drugs in liposomes. JUAREZ, J. C., HERNANDEZ, B. J., and ESTELRICH, J., Biochem. Soc. Trans., 1989, 17, (6), 996–997.
  • Liposomes as drug carriers in the therapy of infectious diseases. JULIANO, R. L., Horiz. Biochem. Biophys., 1989, 9, 249–279.
  • Vaccination against murine cutaneous leishmaniasis by using leishmania major antigen-liposomes: optimization and assessment of the requirement for intravenous immuniz-ation. KARL, L. P., SCOTT, C. A., LELCHUK, R., GREGORIADIS, G., and LIEW, F. Y. J. Immunol., 1989, 142, (12), 4441–4449.
  • Inhibition of tumor growth in the liver by cisplatin encapsulated in large oligolamellar liposomes prepared by freezing and thawing. KALEDIN, VI., NwoLIN, V. P., POPOVA, N. A., BUDKER, V. G., and SEMENOVA, L. A., Vopr. Onkol., 1989, 35, (5), 599–602.
  • Methodology for efficacy study of liposome bronchodilators in long-duration experiments. KAMAREI, A., Womo, A., and MCCALDEN, T., Proc. West Pharmacol. Soc., 1989, 32, 33–35.
  • Kinetic aspects of the oxidation of phosphatidylcholine vesicles and phosphatidylcholine-cholesterol-reconstituted vesicles in water. KANG SOON HEE, PARK JONG Yoorv, KIM KEON, and RHO JUNG Eux, Nonchong-Han'guk Saenghwal Kwahak Yonguwon, 1988, 42, 63–70.
  • Monoclonal antibody interactions with hapten-bearing liposomes. KANTOR, A. B., University of California, Berkeley, CA, USA, Dissertation, 1988, 185 pp.
  • Protein NMR studies of phospholipid vesicles: interactions with n-alcohols. KASZUBA, M., and HUNT, G. R. A., Biochem. Soc. Trans., 1989, 17, (4), 723–724.
  • Purification of DNA-binding transcription factors by their selective adsorption on the affinity latex particles. KAWAGUCHI, H., ASAI, A., OHTSUKA, Y., WATANABE, H., WADA, T., and HANDA, H., Nucleic Acids Res., 1989, 17, (15), 6229–6240.
  • Development of poly(methyl methacrylate) fine particle materials. KAWASE, S., Kobunshi Kako, 1989, 38, (3), 131–138.
  • Preparation of prolonged-release spherical micro-matrix of ibuprofen with acrylic polymer by the emulsion-solvent diffusion method for improving bioavailability. KAWASHIMA, Y., NIWA, T., HANDA, T., TAKEUCHI, H., IwAmoro, T., and ProH, V., Chem. Pharm. Bull., 1989, 37, (2), 425–429.
  • Microencapsulation by hydroprilling. KEGEL, B., Swiss Chem., 1989, 11, (6), 29–30. 32–33.
  • Induction of fusion in aggregated and nonaggregated liposomes bearing cationic detergents. KEREN-ZUR, M., BEIGEL, M., LOYTER, A., Biochim. Biophys. Acta, 1989, 983, (2), 253–258.
  • Employment of magnet-susceptible microparticles for the targeting of drugs. KHARKEVICH, D. A., ALYAUTDIN, R. N., and FILIPPOV, V. I., J. Pharm. Pharmacol., 1989, 41, (4), 286-288. Pharmacological toxicological and chemical studies on 1,2-diaminocyclohexaneplatinum(II) complexes entrapped in multilamellar vesicles. KHOKHAR, A. R., AL-BAKER, S., KRAKOFF, I. H., and PEREZ-SOLER, R. Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 627.
  • Measurement of retinal blood velocity and flow rate in primates using a liposome-dye system. KHOOBEHI, B., PEYMAN, G. A., NIESMAN, M. R., and ONCEL, M., Ophthalmology, 1989, 96, (6), 905–912.
  • Augmentation of direct antiproliferative activity against human bladder cancer lines by interferon alpha encapsulated in liposomes. KILLION, J. J., FAN, D., FRANGOS, D., PRICE, J. E., and FIDLER, I. J., Assoc. Cancer Res. Annu. Meet., 1989, 30, 387.
  • Electron transfer between liposomal cytochrome cl and cytochrome c: catalytic implications of electrostatic potentials. Kim, C. H., KING, T. E., and BALNY, C., Biochem. Biophys. Res. Commun., 1989, 163, (1), 276–283.
  • Shunting of 9-µ microspheres during tooth preparation. Kim, S., DORSCHER-KIM, J., GAYSON, A., and LIu, M., J. Dent. Res., 1989, 68, (Spec. Issue, June), 903.
  • Intestinal absorption of dolichol from emulsions and liposomes in rats. KIMURA, T., TAKEDA, K., KAGEYU, A., TODA, M., KUROSAKI, Y., and NAKAYAMA, T., Chem. Pharm. Bull., 1989,37, (2), 463–466.
  • Dissociation constant of chlorpromazine incorporated in lecithin vesibles determined by proton nuclear magnetic resonance titration. KITAMURA, K., Nooticui, M., NISHIYAMA, C., KOBAYAKAWA, K., Email, T., KUWAHARA, Y., and Hozumi, K., Chem. Pharm. Bull., 1989, 37, (5), 1147–1150.
  • Mutual recognition between polymerized liposomes: macrophage model systems by poly-merized liposomes. KITANO, H., KATO, N., and IsE, N., J. Am. Chem. Soc., 1989, 111, (17), 6809–6813.
  • Liposomes coupled with monoclonal antibodies against glioma-associated antigen for targeting chemotherapy of glioma. KITO, A., YOSHIDA, J., KAGEYAMA, N., KojImA, N., and YAGI, K., J. Neurosurg., 1989, 71, (3), 382–387.
  • Activation of tumoricidal properties in monocytes from cancer patients following intravenous administration of liposomes containing muramyl tripeptide phosphatidylethanola-mine. KLEINERMAN, E. S., MURRAY, J. L., SNYDER, J. S., CUNNINGHAM, J. E., and FIDLER, I. J., Cancer Res., 1989, 49, (16), 4665–4670.
  • Liposome encapsulated gentamicin therapy of Mycobacterium avium complex infection in the beige mouse. KLEMENS, S. P., CYNAMON, M. H., SWENSON, C. E., PALMER, G. S., and GINSBERG, R. S., Abstr. Annu. Meet. Am. Soc. Microbiol., 1989, 89, 164.
  • Therapeutic effects of free or liposome-entrapped doxorubicin on peritoneal implants of mouse colon carcinoma 26. KLEMPERER, J., ARBUCK, S. G., and MAYHEW, E., Proc. Am. Assoc. Cancer. Res. Annu. Meet., 1989, 30, 601.
  • Biotin-bearing p11-sensitive liposomes: high-affinity binding to avidin layer. KLIBANov, A. L., BOGDANOV, A. A., JR, TORCHILIN, V. P., and HUANG, L., J. Lt'posome Res., 1989, 1, (2), 233–244.
  • Photoinduced electron transport across membranes of lipid vesicles containing an osmium tris(bipyridyl) complex. KNERECMAN, E. I., KHANNANOV, N. K., SHAFIROVICH, V. YA., and YABLONSKAYA, E. E., Izv. Akad. Nauk. SSSR, Ser. Khim, (1989, (1), 185–188.
  • Construction of mouse A9 clones containing a single human chromosome tagged with neomycin-resistance gene via microcell fusion. Km, M., Smmizu, M., MoRITA, H., YAMADA, H., and OSHIMURA, M., Jpn. J. Cancer Res., 1989, 80, (5), 413–418.
  • Target cell lysis by cytotoxic T lymphocytes redirected by antibody-coated polystyrene beads. KOLBER, M. A., QUINONES, R. R., and HENKART, P. A., J. Immunol., 1989, 143, (5), 1461–1466.
  • The efficient therapeutic effect of monoclonal antibody conjugated liposomes containing ADM. KONNO, H., SAKAGUCHI, S., KUMAI, K., SUZUKI, H., TSUBOUCHI, T., ISHIBIKI, K., ABE, 0., TADAKUMA, T., YASUDA, T., NAGAIKE, K., et al. Nippon Rinsho, 1989, 47, (6), 1396–1401.
  • Importance of the conjugated antibody for the induction of selective effect of adriamycin conjugated with anti AFP monoclonal antibody and entrapped in liposomes against AFP producing tumors. KONNO, H., KUMAI, K., TSUBOUCHI, T., ISHIBIKI, K., ABE, 0., TADAKUMA, T., YASUDA, T., NAGAIKE, K., HOSOKAWA, S., and SAKAGUCHI, S., Gan to Kagaku Ryoho, 1989,16, (6), 2213–2217.
  • IMX BCM, an automated microparticle enzyme immunoassay for breast cancer mucin. KONRATH, J. G., MANDERINO, G. L., PRZYWARA, L. W., and ELLIOTT, R. L., Glitz. Chem., 1989,35, (6), 1078.
  • Nanoparticle production by microfluidization. KOOSHA, F., and MUELLER, R. H., Arch. Pharm. Weinheim, 1988, 321, (9), 680.
  • The surface chemical structure of poly(beta-hydroxybutyrate) microparticles produced by solvent evaporation process. KOOSHA, F., MULLER, R. H., DAVIS, S. S., and DAVIES, M. C., J. Controlled Release, 1989, 9, (2), 149–157.
  • Reorientational dynamics in lipid vesicles and liposomes studied with ESR: effects of hydration, curvature and unsaturation. KORSTANJE, L. J., VAN-EAASSEN, E. E., and LEVINE, Y. K., Biochim. Biophys. Acta, 1989, 982, (2), 196–204.
  • The effect of liposomes on the adrenoreactivity of the heart papillary muscle. KozLov, A. G., Los, G. V., and STEFANOV, A. V., Fiziol. Zh. SSSR Im. I. M. Sechenova, 1989, 75, (2), 200–204.
  • Microencapsulation of indomethacin by pectin-gelatin complex coacervation method. Ku, Y. S., and CHIN, S. Y., J. Pharm. Soc. Korea, 1989, 33, (3), 191–202.
  • Fate of 14c-terpolymer (14c-labeled-methyl methacrylate-2-hydroxyethyl methacrylate-butyl acrylate) nanoparticles after peroral administration to rats. KUKAN, M., BEZEK, S., KOPRDA, V., LABSKY, J., KALAL, J., BAUEROVA, K., and TRNOVEC, T., Pharmazie, 1989,44, (5), 339–340.
  • Selective and lasting suppressive effect of liposome-entrapped phenytoin on the epileptogenic-ity and status epilepticus originated in the amygdala. KUROKOUCHI, A., MORI, N., and KUMASHIRO, H., Shinkei Seishin Yakuri, 1989, 11, (5), 375–381.
  • Liposomes that can be disintegrated by photo-irradiation. Kusumi, A., NAKAHAMA, S., and YAMAGUCHI, K., Chem. Lett., 1989, (3), 433–436.
  • Study of the interaction of polynucleotides with phosphatidylcholine liposomes and bivalent cations by ESR and proton NMR spectroscopy. KuvicxxiN, V. V., VOLKOVA, L. A., NARYSHKINA, E. P., and IsANGALIN, F. Sh., Biofizika, 1989, 34, (3), 405–409.
  • Fusion of simian immunodeficiency virus (SIV-MAC) with liposomes and erythrocyte ghosts. LARSEN, C., ALFORD, D., YOUNG, L., LEE, K. D., McGRAw, T., and DUZGUNES, N., V International Conference on AIDS: The Scientific and Social Challenge; Montreal, Quebec, Canada, 4-9-June, 1989. R. A. MORISSET (ed.). (International Development Research Centre, Ottawa, Ontario, Canada), publ. 1089, p. 634.
  • Toxicity and antitumor activity of microparticle entrapped cyanomorpholinodoxorubicin. LAUTERSZTAIN, J., ACTON, E. M., PEREZ-SOLER, R., and LOPEZ-BERESTEIN, G., Proc. Am. Assoc. Cancer. Res. Annu. Meet., 1989, 30, 604.
  • Complexing of bovine serum albumin with phosphatidyl choline liposomes. LEBED, 0. I., PRIMAK, R. G., and TISHCHENKO, R. I., Ukr. Biokhim. Zh., 1989, 61, (3), 101–106.
  • Influence of ultrasonic treatment on characteristics of liposome formation. LEBED, 0. I., STEFANOV, A. V., and PRIMAK, R. G. Ukr. Biokhim. Zh., 1989, 61, (3), 96–101.
  • The spectroscopic analysis for binding of amphipathic and antimicrobial model peptides containing pyrenylalanine and tryptophan to lipid bilayer. LEE, S., YOSHIDA, M., MIHARA, H., AOYAGI, H., KATO, T., and YAMASAKI, N., Biochim, Biophys. Acta, 1989, 984, (2), 174–182.
  • Time-resolved fluorimetry of benzo(a)pyrene in liposomes and microsomes. Li, K. P., GLicx, M. R., INDRALINGAM, R., WINEFORDNER, J. D., Proc. Int. Conf. Lasers, 1988, publ. 1989, pp. 580–585.
  • Growth of human immunodeficiency virus and herpes simplex virus type-1 in microen-capsulated human cell cultures in mice. Li, X. Q., ATCHISON, R. W., GORELIK, E., ARMSTRONG, J., and Ho, M., Abstr. Annu. Meet. Am. Soc. Microbiol., 1989, 89, 145.
  • Studies on microencapsulation. Part 16. In vitro dissolution behavior of spansule-type micropellets prepared by the pan coating method. LIN, S. Y., and CHENG, L. L., Pharm. Ind., 1989, 51, (5), 528–531.
  • Iron loading modifies the fatty acid composition of cultured rat myocardial cells and liposomal vesicles: effect of ascorbate and alpha-tocopherol on myocardial lipid peroxidation. LINK, G., PINSON, A., KAHANE, I., and HERSHKO, C., J. Lab. Clin. Med., 1989, 114, (3), 243–249.
  • Characterization of plasma-stabilized liposomes composed of dioleoylphosphatidylethanola-mine and oleic acid. Liu, D. X., ZHOU, F., and HUANG, L., Biochem. Biophys. Res. Commun., 1989, 162, (1), 326–333.
  • Small, but not large, unilamellar liposomes composed of dioleoylphosphatidylethanolamine and oleic acid can be stabilized by human plasma. Liu, D., and HUANG, L., Biochemistry, 1989, 28, (19), 7700–7707.
  • Role of cholesterol in the stability of pH-sensitive, large unilamellar liposomes prepared by the detergent-dialysis method. Liu, D., and HUANG, L., Biochim. Biophys. Acta, 1989, 981, (2), 254–260.
  • Effect of etoposide on the fluidity of dipalmitoylphosphatidylcholine liposome by differential scanning calorimetry and Raman spectroscopy. Liu, F., and LIAO, S. S., Yaoxue Xuebao, 1989, 24, (5), 372–375.
  • Efficacy of liposome-bound amphotericin B for the treatment of experimental fungal endophthalmitis in rabbits. Liu, K. R., PEYMAN, G. A., and KHOOBEHI, B., Invest. Ophthalmol. Vis. Sc., 1989, 30, (7), 1527–1534.
  • The cryoprotection of multilamellar liposomes by carboxylate anions. LLOYD, A. W., RUTT, K. J., OLLIFF, C. J., and HODGES, N. A., J. Pharm. Pharmacol., 1988, 40, (Suppl.), 27 pp. Oncogenic transformation induced by microcell mediated gene transfer. Lu, Y., and BLAIR, D. G., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 452.
  • Surface chemical analysis of copolymer nanoparticles by SSIMS and XPS. LYNN, R. A. P., DAVIES, M. C., DAVIS, S. S., HUMPHREY, P., and HEARN, J., J. Pharm. Pharmacol., 1988, 40, (Suppl.), 130 pp.
  • Preparation and characterization of poly(styrene) microcapsules containing corrosion inhibi-tors. MAC, A., NEGI, D., and FRIEND, D., J. Microencapsul., 1989, 6, (3), 361–367.
  • Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide. MACEWEN, E. G., KURZMAN, I. D., RosENTHAL, R. C., SMITH, B. W., MANLEY, P. A., J. Natl Cancer Inst., 1989, 81, (12), 935–938.
  • Scanning and transmission electron microscopy of biodegradable microspheres (DSM) in blood vessels. MAKITA, T., ICHIMAL, H., KAGABU, S., MANBA, K., NAITO, I., LINDBLOM, R., HATSUOKA, M., and OKAWA, T., Cell. Biol. Int. Rep., 1989, 13, (5), 427–436.
  • Intraperitoneal administration of liposome encapsulated muramyl-tripeptide phospho-ethanolamine (MTP-PE) with or without recombinant murine GM-CSF to athymic mice bearing human ovarian cancer xenografts. MALIK, S. T. A., BALKWILL, F. R., and HART, I. R., Proc. Am. Assoc. Cancer Res. Annu. Meet. 1989, 30, 411.
  • Cationic liposome-mediated RNA transfection. MALONE, R. W., FELGNER, P. L., and VERMA, I. M., Proc. Nail Acad. Sci. USA, 1989, 86, (16), 6077–6081.
  • Testing of a film of wet microspheres in an anaerobic fermentation tank. MARCINIAK, K., Gaz. Cukrow, 1989, 97, (1), 16–17.
  • Encapsulation of vitamin A. MARKUS, A., and PELAH, Z., J. Microencapsul., 1989, 6, (3), 389-394. Novel preparation of zein microspheres conjugated with PS-K available for cancer immuno- therapy. MATSUDA, Y., SUZUKI, T., SATO, E., SATO, M., KOIZUMI, S., UNNO, K., and KATO, T., Chem. Pharm. Bull., 1989, 37, (3), 757–759.
  • Liposome mediated dissipation of valinomycin-imposed potassium potential across erythrocyte membrane. MATSUDARIA, R., and NAKAE, T., Tokai J. Exp. Clin. Med., 1987, 12, (4), 253–261.
  • A kinetic analysis of proton transport in bacteriorhodopsin liposomes. MATSUOKA, H., Kagaku Kogaku, 1989, 53, (6), 400–402.
  • Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells. MATTAHY, K. K., ABA, A. M., COBB, S., HONG, K., PAPAHADJOPOULOS, D., and STRAUBINGER, R. M., Cancer Res., 1989, 49, (17), 4879–4886.
  • Liposome-trapped nystatin in growth inhibition of Aspergillus niger. MAZUMDER, C., KUNDU, M., BASU, J., CHAKRABARTI, P., J. Liposome Res., 1989, 1, (2), 167–175.
  • Bronchodilator efficacy of liposome formulations of metaproterenol sulfate in the anesthe-tized guinea pig. MCCALDEN, T. A., ABRA, R. M., and MIFIALKO, P. J., J. Liposome Res., 1989, 1, (2), 211–222.
  • Studies on the microencapsulation of rat pancreatic cell line AR-42J. MCCARTHY, U., MCHALE, A. P., and MCHALE, M. L., Biochem. Soc. Trans., 1989, 17, (2), 393–394.
  • The in vitro percutaneous absorption of stanozolol from liposomes solutions and oil-in-water creams. McGuux, J. G., SANDHU, G., LENDREM, D. W., POTTER, C. J., and Ross, A. R., J. Pharm. Pharmacol., 1988, 40, (Suppl.), 47 pp.
  • The effect of hematoporphyin derivative and human erythrocyte ghost encapsulated hema-toporphyrin derivative on a mouse myeloma cell line. MC HALE, A. P., MCHALE, M. L., and BLAU, W., Cancer Biochem. Biophys., 1988, 10, (2), 157–164.
  • Tumor suppressor activity of microcell transferred human chromosomes in lung carcinoma cells. MC MENAMIN, M. G., NAN, D. S., STANBRIDGE, E. J., SHOWS, T. B., and HARRIS, C. C. Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 189.
  • Production of multilamellar, small unilamellar and reverse-phase liposomes containing house dust mite allergens. Potential adjuvants in the immunotherapy of allergic disease. McWtLLIAm, A. S., and STEWART, G. A., J. Immunol. Methods, 1989, 121, (1), 53–60.
  • Tocopheroxyl radical persistence and tocopherol consumption in liposomes and in vitamin E-enriched rat liver mitochondria and microsomes. MEHLHORN, R. J., SumIDA, S., and PACKER, L., J. Biol. Chem., 1989, 264, (23), 13448–13452.
  • Encapsulating all- trans-retinoic acid (RA) in liposomes reduces its toxic effects while maintaining its anti-tumor properties. MEHTA, K., and PRATT, J. A., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 605.
  • Liposomes as drug carriers for polyene antibiotics. MEHTA, R. T., Adv. Drug Delivery Rev., 1989,3, (3), 283–306.
  • Liposomal pulmonary drug delivery. I. In vivo disposition of atropine base in solution and liposomal form following endotracheal instillation to the rabbit lung. MEISNER, D., PRINGLE, J., and MEZEI, M., J. Microencapsul., 1989, 6, (3), 379–387.
  • In vitro release and depot effect after intratumoral application of metrizamide-containing liposomes. MENTRUP, E., WOWRA, B., ZELLER, W. J., STURM, V., and STRICICER, H., Arz-neimittelforschung, 1989, 39, (4), 421–423.
  • A new approach to encapsulating nonsteroidal anti-inflammatory drugs. III. Coating acidic as well as basic nonsteroidal anti-inflammatory drugs with cellulose derivatives having different functional groups. MESHALI, M. M., EL-DIEN, E. Z., OMAR, S. A., and Luzzi, L. A., J Microencapsul., 1989, 6, (3), 339–353.
  • A new approach to encapsulating nonsteroidal anti-inflammatory drugs. IV. Effect of cellulose derivatives with different functional groups on the bioavailability and gastric ulcero-genic activity of acidic as well as basic nonsteroidal anti-inflammatory drugs. MESHALI, M. M., EL-DIEN, E. Z., OMAR, S. A., and Luzzi, L. A., J. Microencapsul., 1989, 6, (3), 355–360.
  • Phosphatidylcholine liposomes as carriers for etretinate. MICHAELIS, L., SCHROEDER, E., and WIRTH, K. E., Naunyn Schmiedeberg's Arch. Pharrnacol., 1989, 339, (suppl.), RI.
  • Effect of cholesterol on the DOPA oxidase of liposome-integrated mushroom tyrosinase. MIRANDA, M., AMICARELLI, F., RAGNELLI, A. M., POMA, A., and ARCADI, A., Colloids Surf., 1989, 35, (2-4), 353–358.
  • Formation and properties of monopolar-bipolar mixed lipid vesicles. MIRGHANI, Z., BERTOIA, D., PIANO, E., and Guozzi, A., Biochem. Soc. Trans., 1989, 17, (3), 507–508.
  • Phase separation in bimolecular mixed lipid membranes induced by polylysine. MITTLER-NEHER, S., and KNOLL, W., Biochem. Biophys. Res. Commun., 1989, 162, (1), 124–129.
  • Application of liposomes in non-isotopic immunoassays: a review. MoNji, N., COLE, C. A., and CASTRO, A. In Reviews on Immunoassay Technology, S. B. PAL (ed.) (Chapman and Hall: New York, N.Y., USA), 1988, vol. 2, pp. 73–84.
  • Sidedness of yeast plasma membrane vesicles and mechanisms of activation of the ATPase by detergents. MONK, B. C., MONTESINOS, C., LEONARD, K., and SERFtANO, R., Biochim. Biophys. Acta., 1989, 981, (2), 226–234.
  • Suppressive effect of GABA-containing liposomes on kindled convulsion. Mom, N., TERAYAMA, K., SATO, T., and KUMASHIRO, H., No To Shinkei, 1989, 41, (2), 193–198.
  • Preparation and in-vitro evaluation of cellulose acetate phthalate (CAP) microcapsules. MORTADA SANA, A. M., Alexandria J. Pharm. Sci., 1989, 3, (1), 1–5.
  • Hemoglobin niosomes. I. Preparation, functional and physico-chemical properties, and stability. MOSER, P., MARCHAND-ARVIER, M., LABRUDE, P., HANDJANI VILA, R. M., and VIGNERON, C., Pharm. Acta Hely., 1989, 64, (7), 192–202.
  • Liposomes as bioreactors transport phenomena in proteoliposomes. MOSSA, G., ANNESINI, M. C. DI GIULIO, A., DINI, L.,, and FINAZZI AGRO, A. In Progress in Clinical and Biological Research, D. A. BUTTERFIELD (ed.) (A. R. Liss: New York, N.Y., USA), 1989, vol. 292, pp. 227–236.
  • Uptake of inert particles by dog alveolar macrophages in vitro-a comparison of monolayer and suspension techniques. MUELLER, H. L., GUILMETTE, R. A., and MUGGENBURG, B. A., J. Appl. Toxicol., 1989, 9, (3), 135–143.
  • Studies on the effectiveness of hyperthermia combined with arterial therapeutic blockage in the treatment of tumors Part 3. Clinical studies on the effectiveness of hyperthermia combined with arterial chemo-embolization using degradable starch microspheres (DSM). MURATA, T., J. Jpn Soc. Cancer Ther., 1988, 23, (11), 2725–2731.
  • Studies on the effectiveness of hyperthermia combined with arterial therapeutic blockage in the treatment of tumors Part 2. Experimental studies on the effectiveness of hyper-thermia combined with arterial embolization using degradable starch microspheres (DSM). MURATA, T., J. Jpn. Soc. Cancer Ther., 1988, 23, (11), 2717–2724.
  • Influence of the diameter of the drug carriers for accumulation to tumors. MUROTA, H., GOTO, A., and UNNO, K., Nippon Rinsho, 1989, 47, (6), 1363–1368.
  • Reconstitution of calcium channel (CACH) purified from porcine ventricular muscle into liposomes and its characterization. NAITOH, T., TOYO-OKA, T., and SUGIMOTO, T., J. Mel. Cell. Cardiol., 1989, 21, (Suppl. 2), S177.
  • Preparation of bovine serum albumin nanospheres as drug targeting carriers. NAKAGAWA, Y., TAKAYAMA, K., UEDA, H., MACHIDA, Y., and NAGAI, T., Drug. Des. Deliv., 1987, 2, (2), 99–107.
  • A liposome immunoassay based on a chemiluminescence reaction. NAKAMURA, T., HOSHINO, S., HAZEMOTO, N., HAGA, M., KATO, Y., and SUZUKI, Y., Chem. Pharm. Bull., 1989, 37, (6), 1629–1631.
  • Effects of synthetic bioactive lipids on the activity of n-beta-hydroxybutyrate dehydrogenase, a membrane enzyme. NASSER, B., MORPAIN, C., LAUDE, B., and LATRUFFE, N., C. R. Soc, Biol. (Paris), 1988, 182, (6), 565–571.
  • Differential effects of liposome-entrapped desferrioxamine on proliferation and erythroid differentiation of murine erythroleukemic Friend cells. NASTRUZZI, C., WALDE, P., MENEGATTI, E., and GAMBARI, R., Biochim. Biophys. Acta, 1989, 1013, (1), 36–41.
  • Antileishmanial effect of free and encapsulated sinefungin against Leishmania donovani infections in BALB/c mice. NEAL, R. A., Twos', M. V., and ROBERT, G. M., C. R. Acad. Sci., Ser. 3, 1989, 308, (18), 485–488.
  • Liposome-dependent delivery of pteridine antifolates: a two-compartment growth inhibition assay for evaluating drug leakage and metabolism. NG-KAYUN, HEATH, T. D., Biochim. Biophys. Acta, 1989, 981, (2), 261–268.
  • Efficacy of various treatment regimens, using liposomal streptomycin in cows with brucellosis. NICOLETTI, P., LENK, R. P., POPESCU, M. C., and SWENSON, C. E., Am. J. Vet. Res., 1989, 50, (7), 1004–1007.
  • Liposome encapsulated manganese chloride as a liver specific contrast agent for magnetic resonance imaging. NIESMAN, M. R., University of Illinois, Urbana, IL, USA, Dissertation, 1988, 137 pp.
  • Liposome fusion catalytically induced by phospholipase C. NIEVA, J. L., Goxi, F. M., and ALONSO, A., Biochemistry, 1989, 28, (18), 7364–7367.
  • Preparation and evaluation of albumin microspheres and microcapsules containing cisplatin. NISHIOKA, Y., KYOTANI, S., OKAMURA, M., MORI, Y., MIYAZAKI, M., OKAZAKI, K., OHNISHI, S., YAMAMOTO, Y., and IT°, K., Chem. Pharm. Bull., 1989, 37, (5), 1399–1400.
  • Properties of sorbents based on divinylbenzene copolymers with fumaric acid and maleic acid derivatives. NOVIKOV, 0. N., TSARIK, L. YA., and UMANETS, V. V., Plast. Massy, 1989, (5), 20–23.
  • Poly(buty1-2-cyanoacrylate) particles as adjuvants for oral immunization. O'HAGAN, D. T., PALIN, K., J., and DAVIS, S. S., Vaccine, 1989, 7, (3), 213–216.
  • Recoverable semipermeable microencapsulated DNA surrogates for monitoring the colorectal cavity in situ effects of fiber and meat in human diets on benzo-a-pyrene and possible endogenous cross-linking agents. O'NEILL, I. K., POVEY, A. C., BINGHAM, S., BROUET, I., BEREZIAT, J. C., ELLuL, A. In IARC (International Agency for Research on Cancer) Scientific Publications, No. 89. H. BARTSCH, K. HEMMINKI, and I. K. O'NEILL (Eds.) (Oxford University Press: Oxford, UK), 1988, pp. 107–112.
  • Synovial accumulation of technetium-99M labelled liposomes in rheumatoid arthritis. O'SULLIVAN, M. M., Amos, N., LOVE, W., MORGAN, J. R., and WILLIAMS, B. D., Arthritis Rheum., 1989, 32, (4, Suppl.), S15.
  • Controlled release of LH-RH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and pharmacological effects in animals. OGAWA, Y OICADA, H., HEYA, T., and SHIMAMOTO, T., J. Pharm. Pharmacol., 1989, 41, (7), 439–444.
  • Production of micro-gel beads by a rotating disk atomizer. OGBONNA, J. C., MATSUMURA, M., YAMAGATA, T., SAKUMA, H., and KATAOKA, H., J. Ferment. Bioeng., 1989, 68, (1), 40–48.
  • Effect of antibiotics on CR1 receptor levels of human neutrophils and on the binding and phagocytosis of opsonized polystyrene microspheres by these leucocytes. OGLE, J. D., NOEL, J. G., SRAMKOSKI, R. M., OGLE, C. K., and ALEXANDER, J. W., Burns, 1989, 15, (3), 141–144.
  • Formulation factors of fenvalerate microcapsules influencing insecticidal efficacy and fish toxicity. OFITSUBO, T., TAKEDA, H., TSUDA, S., KAGOSHIMA, M., and Tsuji, K., Nippon Noyaku Gakkaishi, 1989, 14, (2), 235–239.
  • Implication of activation of intraperitoneal macrophages with biodegradable microspheres. OKAWA, T., ICHIMAL, H., ISHIDA, T., KAWATA, M., KAGUBA, S., MAMBA, K., and MAKITA, T., Cell. Biol. Int. Rep., 1989, 13, (6), 547–553.
  • Partition coefficients of dopamine antagonists in brain membranes and liposomes. OLIVEIRA, C. R., LIMA, M. C. P., CARVALHO, C. A. M., LEYSEN, J. E., and CARVALHO, A. P., Biochem. Pharmacol., 1989, 38, (13), 2113–2120.
  • Lipid peroxidation of phosphatidylcholine liposomes depressed by the calcium channel blockers nifedipine and verapamil and by the antiarrhythmic-antihypoxic drug stoba-dine. ONDRIAS, K., Mimic, V., GERGEL, D., and STASKO, A., Biochim. Biophys. Acta, 1989, 1003, (3), 238–245.
  • Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-bone tumor antigen monoclonal antibody in leukemic cows. Zentralbl. Veterinarmed. (B), 1989, 36, (2), 139–147.
  • Use of liposomes as injectable-drug delivery systems. OSTRO, M. J., and Cutus, P. R., Am. J. Hosp. Pharm., 1989, 46, (8), 1576–1587.
  • Microparticle enzyme immunoassay for the measurement of antibodies to hepatitis B surface antigen IMX anti-HBS. OSTROW, D. H., IRACE, H. JR, MACIOSZEK, J., SWANSON, S. M., and EDWARDS, B. M., Clin. Chem., 1989, 35, (6), 1193.
  • Structural modifications of lipid vesibles by 8-methoxypsoralen. PALI, T., EBERT, B., and HORVATH, L. I., J. Photochem. Photobiol, B, 1989, 3, (3), 359–367.
  • Immunogenicity of a ribonucleic acid-protein fraction of Mycobacterium tuberculosis encapsulated in liposomes. PANCHOLI, P., VINAYAK, V. K., and KHULLER, G. K., J. Med. Microbiol., 1989, 29, (2), 131–138.
  • Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: a quantitative model for M cell uptake. PAPPO, J., and ERMAK, T. H., Clin. Exp. Immunol., 1989, 76, (1), 144–148.
  • Transcytosis of drug carriers carrying peptides across epithelial barriers. PATEL, H. M., Biochem. Soc. Trans., 1989, 17, (5), 940–942.
  • Chloroquine containing liposomes in the chemotherapy of murine malaria. PEETERS, P. A. M., HUISKAMP, C. W. E. M., ELING, W. M. C., and CROMMELIN, D. J. A., Parasitology, 1989, 98, (3), 381–386.
  • Therapeutic effect of chloroquine (CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: comparison with combinations of antibodies and CQ or liposomal CQ. PEETERS, P. A. M., BRUNINK, B. G., ELING, W. M. C., and CROMMELIN, D. J. A., Biochim. Biophys. Acta., 1989, 981, (2), 269–276.
  • Morphological characterization of liposomes in ultrathin sections. PEREVERZEV, N. A., KuLutov, V. I., POPOV, V. L., GRIGORYAN, G. Yu., Zh. Mikrobiol. Epidemiol. Immunobiol., 1989, (6), 107–109.
  • Liposomes as carriers of antitumor agents: toward a clinical reality. PEREZ-SOLER, R., Cancer. Treat. Rev., 1989, 16, (2), 67–82.
  • Preclinical toxicity and pharmacology of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(H). PEREZ-SOLER, R., LAUTERSZTAIN, J., STEPHENS, L. C., WRIGHT, K., and KHOKHAR, A. R., Cancer Chemother. Pharmacol., 1989, 24, (1), 1–8.
  • Interactions of parvalbumins with model phospholipid vesicles. PERMYAKOV, E. A., KREIMER, D. I., KALINICHENKO, L. P., ORLOVA, A. A., and SHNYROV, V. L., Cell Calcium, 1989, 10,(2), 71–79.
  • Stimulatory effect of liposomes on experimental influenza infection. PETROVA, I. G., SLEPUSHKIN, V. A., and BUKRINSKAYA, A. G., Vopr. Virusol., 1988, 33, (6), 662–663.
  • Liposomes as immune adjuvants. PHILLIPS, N. C., Proc. West Pharmacol., Soc., 1989, 32, 107-110. Generic liposome reagent for immunoassays. PLANT, A. L., BRIZGYS, M. V., LOCASIO-BROWN, L., and DURST, R. A., Anal. Biochem., 1989, 176, (2), 420–426.
  • Inhibition of HIV replication by liposomal encapsulated amphotericin B. PONTANI, D. R., SUN, D., BROWN, J. W., SHAHIED, S. I., PLESC1A, 0. J., SCI1AFFNER, C. P., LOPEZ-BERESTEIN, G., and SARIN, P. S., Antiviral Res., 1989, 11, (3), 119–125.
  • Photooxidation of cell membranes using eosin derivatives that locate in lipid or protein to study the role of diffusible intermediates. POOLER, J. P., Photochem. Photobiol., 1989, 50, (1), 55–68.
  • Use of microencapsulated fireproofing compounds for decreasing the combustibility of polymers. POPOVA, T. V., KHALTURINSKII, N. A., VILESOVA, M. S., and BERLIN, A. A., Goryuchest Polimer Mater, Volgograd, 1987, 173–196.
  • Liposomal amiodarone: electrophysiologic and pharmacodynamic correlates with a novel site specific delivery system. PORTER, R. S., SHELDON, J. H., FRASCH, F., NYDEGGER, C., SLEGOWSKI, M. B., MEADOWS, G., and JENDRASIAK, G., J. Mol. Cell. Cardiol., 1989, 21, (Suppl. 2), S8.
  • Purification of avidin from egg whites using affinity-modified unilamellar vesicles. POWERS, J. D., KILPATRICK, P. K., and CARBONELL, R. G., Prog. Clin. Biol. Res., 1989, 292, 237–246.
  • Compression of microcapsules I: effect of excipients and pressure on drug release. PRAPAITRAKUL, W., and WHITWORTH, C. W., Drug Dev. Ind. Pharm., 1989, 15, (12), 2049–2053.
  • Encapsulation of cytosine arabinoside in liposomes: a method of manipulating in vivo pharmacokinetics in man. PRICE, C., AHERNE, W., NEW, R., MAYHEW, E., STRINGER, R., LITTLETON, P., ADAMS, K., and RUSTUM, Y., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 248.
  • Comparison of steady-state fluorescence polarization and urea permeability of phosphatidyl-choline and phosphatidylsulfocholine liposomes as a function of sterol structure. PuGH, E. L., BITTMAN, R., FUGLER, L., and KATEs, M., Chem. Phys. Lipids, 1989, 50, (1), 43–50.
  • The effect of cecropins B and D from the Chinese oak silk moth (Antheraea pernyi) on liposomes. QU XIANMING, TANG HA1LUN, and HAAKAN STEINER, Shengtvu Huaxue Yu Shengtvu Wuli Xuebao, 1989, 21, (1), 35–42.
  • Mapping neuronal inputs to REM sleep induction sites with carbacholfluorescent micro-spheres. QUATTROCH1, J. J., MAMELAK, A. N., MADISON, R. D., MACKLIS, J. D., and HOBSON, J. A., Science, 1989, 245, (4921), 984–986.
  • Binding of crotoxin, a presynaptic phospholipase A2 neurotoxin, to negatively charged phospholipid vesicles. RADVANYI, F., SALIOU, B., LEMBEZAT, M. P., and BON, C. J. Neurochem, 1989, 53, (4), 1252–1260.
  • The polyene antibiotic amphotericin B acts as a calcium ionophore in sterol-containing liposomes. RAMOS, H., ATTIAS DE MURCIANO, A., COHEN, B. E., and BOLARD, J., Biochim. Biophys. Acta, 1989, 982, (2), 303–306.
  • A novel in situ method to test polymers and coated microparticles for bioadhesion. RAO, K. V. R., and BURI, P., Int. J. Pharm., 1989, 52, (3), 265–270.
  • Prednisolone 21-acetate poly(glycolic acid) microspheres: influence of matrix characteristics on release. REDMON, M. P., HICKEY, A. J., and DELucA, P. P., J. Controlled Release, 1989,9, (2), 99–109.
  • Preparation and in vitro activity of liposome encapsulated opioicls. REIG, F., ALSINA, M. A., BUSQUETS, M. A., VALENCIA, G., and GARCIA-ANTON, J. M., J. Microencapsul., 1989, 6, (3), 277–283.
  • Vaccination of mice against murine coccidiosis by ingestion of surface proteins of Eimeria falciformis incorporated in liposomes. RHALEM, A., BEKHTI, K., BOURDIEU, C., LUFFAU, G., and PERY, P., C. R. Acad. Sci. (III), 1989, 309, (1), 19–23.
  • The D-glucose transporters of Rhodotorula glutinis. RITCHIE, C. K., University of Miami, Oxford, OH, USA, Dissertation, 1988, 137 pp.
  • Phospholipid stereospecificity in liposomal modulation of nitrogen mustard action. RITTER, C., PROOD, C., and RUTMAN, R. J., NATO ASI Ser., Ser. A, 1988, 155, 137–141.
  • The production of stable protein-coated microspheres as a model system for studying the oral delivery of potential vaccinating agents. ROBERTS, M. J. J., WILLIAMS, P., DAVIS, S. S., and DAVIES, M. C., Arch. Pharm. Weinheim, 1988, 321, (9), 621.
  • Increase of doxorubicin penetration in cultured rat hepatocytes by its binding to polymeth-acrylic nanoparticles. ROLLAND, A., BEGUE, J. M., LE VERGE, R., and GUILLOUZO, A., Int. J. Pharm., 1989, 53, (1), 67–74.
  • Blood clearance and organ distribution of intravenously administered polymethacrylic nanoparticles in mice. ROLLAND, A., COLLET, B., LE VERGE, R., and TOUJAS, L., J. Pharm. Sci., 1989, 78, (6), 481–484.
  • DNA introduction into plant cells using liposomes. ROSENBERG, N., REICHENBACH-DEKEL, M., NAVOT, N., GAD, A. E., ALTMAN, A., and CZOSNEK, H., Plant Physiol., 1989, 89, (4, Suppl.), 46.
  • Cell-density-dependent lysis and sporulation of Myaococcus aanthus in agarose microbeads. ROSENBLUH, A., NIB, R., SAHAR, E., and ROSENBERG, E., J. Bacteriol., 1989, 171, (9), 4923-4929. Stimulation of cation transport in mitochondria by gramicidin and truncated derivatives. ROTTENBERG, H., and KOEPPE, R. E., Biochemistry, 1989, 28, (10), 4361–4367.
  • Multivesicular liposomes (MVL) containing bleomycin (B) for subcutaneous (SC) administration. ROY, R., and KIM, S., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 604. Reaction of microparticles by the diffusion of reactive gases through porous shells. RUBEL, G. O., and GENTRY, J. W., Report, 1988 (CRDEC-TR-88076; Order No. AD-A196656), 25 pp. Effects of normalization errors on size distributions obtained from dynamic light scattering data. RUF, H., Biophys. J., 1989, 56, (1), 67–78.
  • Ligand inhibition of the platelet glycoproteins lib-Illa complex function as a calcium channel in liposomes. RYBAK, M. E., and RENZULLI, L. A., J. Biol. Chem., 1989, 264, (25), 14617–14620.
  • Evaluation of sustained-release suppositories containing microencapsulated theophylline and oxyphenbutazone. SAFWAT, S. M., and EL-SHANAWANY, S. J. Controlled Release, 1989, 9, (1), 65–73.
  • Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules. SAIKI, I., IIDA, J., MURATA, J., OGAWA, R., Nistu, N., SUGIMURA, K., TOKURA, S. and AZUMA, I., Cancer Res., 1989, 49, (14), 3815–3822.
  • Chemoembolization using microencapsulated anticancer drugs. SATO, K., and KATO, T., Nippon Rinsho, 1989, 47, (6), 1379–1383.
  • Targetability of cell-specific liposomes coated with polysaccharide-cholesterol derivatives. SATO, T., Nippon Rinsho, 1989, 47, (6), 1402–1407.
  • The uptake of drug-loaded microspheres by mouse peritoneal macrophages in vitro. SAUNDERS, J., DAVIS, S. S., SMITH, A.,and WILSON, C. G., J. Pharm. Pharmacol., 1988, 40, (Suppl.), 29 pp.
  • Arrest and retention of multilamellar liposomes in the brain of normal mice or mice bearing experimental brain metastases. SCHACKERT, G., FAN, D., NAYAR, R., and FIDLER, I. J., Se. Cancer Ther., 1989, 5, (2), 73–79.
  • Targeting of liposomes to liver cells. SCHERPHOF, G. L., SPANJER, H. H., DERKSEN, J. T. P., LAZAR, G., and ROERD1NK, F. H., Horiz. Biochem. Biophys. 1989, 9, 281–291.
  • In vivo uptake, and processing of liposomes by parenchymal and non-parenchymal liver cells; application to immunotherapeutic treatment of hepatic metastases. SCHERPHOF, G. L., DAsmAN, T., DERKSEN, H., LAZAR, G., SPANJER, H. H., and ROERDINK, F. H., NATO ASI Ser., Ser. A, 1988, 155, 109–120.
  • Neutrophil-mediated transfer of polar substances from liposomes to mammary tumor cells in vitro. SCIESZKA, J. F., AEED, P. A., WELCH, D. R., and Clio, M. J., Int. J. Pharm., 1989, 53, (2), 167–173.
  • A phase II trial testing 6-aminochrysene (6-AC) entrapped into sonicated liposomes in advanced breast cancer patients (PTS) with liver metastasis and including a biodistri-bution study of the liposomes. SCULIER, J. P., LADURON, C., BRASSINNE, C., HOLVOET, C., HOLLAERT, C., PICCART, M., FRUHLING, J., and COUNE, A., Assoc. Cancer Res. Annu. Meet., 1989, 30, 272.
  • Pharmacokinetics of amphotericin B in patients receiving repeated intravenous high doses of amphotericin B entrapped into sonicated liposomes. SCULIER, J. P., DELCROIX, C., BRASSINNE, C., LADURON, C., HOLLAERT, C., and COUNE, A., J. Liposome Res., 1989, 1, (2), 151–166.
  • Dehydration-rehydration vesicle methodology facilitates a novel approach to antibody binding to liposomes. SENIOR, J., and GREGORIADIS, G. Biochim. Biophys. Acta., 1989, 1003, (1), 58–62.
  • Intraarterial yttrium-90 class microspheres for therapy of hepatic metastasis: preliminary results. SHAPIRO, B., ANDREWS, J., FIG, L., CAREY, J., WALKER-ANDREWS, S., SMITH, J., and ENSMINGER, W., J. Nucl. Med., 1989, 30, (5, Suppl.), 836–837.
  • The hydration dynamics of proteins incorporated into liposomes. SHHAN, A. A., and MALIUTA, N. P., Biol. Nauki., 1989, (5), 107–111.
  • Granuloma formation by artificial microparticles in vitro. Macrophages and monokines play a critical role in granuloma formation. SHIKAMA, Y., KOBAYASHI, K., KASAHAFtA, K., KAGA, S., HASHIMOTO, M., YONEYA, I., HOSODA, S., SOEJIMA, K., IDE, H., and TAKAHASHI, T., Am. 3. Pathol., 1989, 134, (6), 1189–1199.
  • Augmented antiproliferative effects mediated by interferon-alpha (IFN-alpha) encapsulated in liposome against a newly established human lung cancer cell line. SHIN, D. M., KILLION, J., BUCANA, C., FAN, D., HONG, W. K., and FIDLER, I. J., Assoc. Cancer Res. Annu. Meet., 1989, 30, 389.
  • Effect of polyisobutylene and sealant treatments on ethyl cellulose-walled methyldopa microcapsules. SHIN SANG CHUL, and Kon, Ix BAE., Yakche Hakhoechi, 1989, 19, (1), 29–37. On the dynamics of hydration of proteins incorporate in liposomes. SHIYAN, A. A., and MALYUTA, N. P., Biol. Nauki (Moscow), (5), 107–111.
  • Effect of drug (core) particle size on the dissolution of theophylline from microspheres made from low molecular weight cellulose acetate propionate. SHUKLA, A. J., and PRICE, J. C., Pharm. Res., 1989, 6, (5), 418–421.
  • Construction of a microcell hybrid panel containing different neogene insertions in mouse chromosome 17 used for chromosome-mediated gene transfer. SIDEN, T. S., HOEGLUND, M., and ROEHME, D., Somatic Cell Mol. Genet., 1989, 15, (3), 245–253.
  • Physiological levels of diacylglycerols in phospholipid membranes induce membrane fusion and stabilize inverted phases. SIEGEL, D. P., BANSCHBACH, J., ALFORD, D ELLENS, H., Lis, L. J., QUINN, P. J., YEAGLE, P. L., and BENTZ, J., Biochemistry, 1989, 28, (9), 3703–3709.
  • Active transport of lead by the calcium pump in human red cell ghosts. SIMONS, T. J., J. . Physiol. (Lond.), 1988, 405, 105–113.
  • Binding of 124-kilodalton oat phytochrome to liposomes and chloroplats. SINGH, B. R., CHoi JUNG KAP, KIM IN Soo, and SONG PILL SOON, Physiol. Plant., 1989, 76, (3, Part 1), 319–325.
  • Targeting of methotrexate-containing liposomes with a monoclonal antibody against human renal cancer. SINGH, M., GHOSE, T., FAULKNER, G., KRALOVEC, J., and MEZEI, M., Cancer Res., 1989, 49, (14), 3976–384.
  • Differences in intracellular transport of a fluorescent phosphatidylcholine analog in established cell lines. SLEIGHT, R. G., and ABANTO, M. N., J. Cell Sci., 1989, 93, (2), 363–374.
  • Isolation of the proton-translocating FOF1-ATPase from Rhodospirillum rubrum chromato-phores, and its functional reconstitution into proteoliposomes. SLOOTEN, L., and VANDENBRANDEN, S., Biochim. Biophys. Acta, 1989, 975, (1), 148–157.
  • Liposomes prepared dynamically by interactions between bile salt and phospholipid mole-cules. Sox, K., and ALKAN, H., Biochim. Biophys. Acta, 1989, 981, (2), 288–294.
  • Biodegradable microparticles for delivery of polypeptides and proteins. SPENLEHAUER, G., SPENLEHAUER-BONTHONNEAU, F., and THIES, C. In Progress in Clinical and Biological Research, D. A. BUTTERFIELD (ed.) (A. R. Liss: New York, N. Y., USA), 1989, vol. 292, pp. 283–292.
  • Evaluation of sustained release aqueous suspensions containing microencapsulated drug-resin complexes. SPROCKEL, 0. L., and PRICE, J. C., Drug. Dev. Ind. Pharm., 1989, 15, (8), 1275–1288.
  • In Vitro/ in vivo evaluation of a liquid sustained-release dosage form of chlorpheniramine. SPROCKEL, 0. L., PRICE, J. C., JENNINGS, R., TACKETT, R. L., HEMINGWAY, S., CLARK, B., and LASKEY, R. E., Drug. Dev. Ind. Pharm., 1989, 15, (9), 1393–1404.
  • Evaluation of sustained release aqueous suspensions containing microencapsulated drug-resin complexes. SPROCKEL, 0. L., and PRICE, J. C., Drug. Dev. Ind. Pharm., 1989, 15, (8), 1275–1287.
  • Detection of antibody to hepatitis B core antigen using an automated microparticle based EIA. SPRONK, A. M., PAVLIS-JENKINS, L., SCHMIDT, L. S., TASKAR, S., and BRADY, J. A., Gilts. Chem., 1989, 35, (6), 1193.
  • Liposomes for targeted delivery of radioiodinated IVdU and 3-CH3-IVdU for non-invasive detection of herpes simplex virus encephalitis in mice. STHAKI, S., WIEBE, L. I., KNAUS, E. E., ROGERS, J. A., TOVELL, D., and TYRRELL, D. L., Drug Des. Deliv., 1988, 3, (3), 223-234. Liposome encapsulation of doxorubicin: pharmaceutical and therapeutic aspects. STORM, G., VAN BLOOIS, L., STEERENBERG, P. A., VAN ETTEN, E., DE GROOT, G., and CROMMELIN, D. J. A., J. Controlled Release, 1989, 9, (3), 215–229.
  • Processing of doxorubicin-containing liposomes by liver macrophages in vitro. STORM, G., REGTS, J., BEIJNEN, J. H., and ROERDINK, F. H., J.
  • Liposome Res., 1989, 1, (2), 195-210. Liposomes: from theoretical model to cosmetic tool. STRAUSS, G., J. Soc. Cosmet. Chem., 1989,40, (1), 51–60.
  • Lecithin : cholesterol acyltransferase activation by synthetic amphipathic peptides. SUBBARAO, N. K., FIELDING, C. J., HAMILTON, R. L., and SZOKA, F. C. Jr. Proteins, 1988, 3, (3), 187–198.
  • Calcification of a collagen-liposome complex. SUDDHASTHIRA, T., Houston Graduate School of Biomedical Sciences, University of Texas, Houston, TX, USA, Dissertation, 1988, 118 pp.
  • Basic amphipathic helical peptides induce destabilization and fusion of acidic and neutral liposomes. SUENAGA, M., LEE, S., PARK, N. G., AOYAGI, H., KATO, T., UMEDA, A., and AMAKO, K., Biochim. Biophys. Acta, 1989, 981, (1), 143–150.
  • Preparation and properties of lipolysosornes from newly hatched chick liver. SUGAWARA, E., Shikoku Igaku Zasshi, 1988, 44, (5/6), 296–304.
  • Effect of phosphatidylcholine liposomes on cultured hepatocytes: observations by the plasma polymerization replica method and tem. Sujima, H., NAGAMORI, S., FUJISE, K., HASUMURA, S., HOMMA, S., MATSUURA, T., SHIMIZU, K., NIIYA, M., and KAMEDA, H., J. Clin. Electron. Microsc., 1988, 21, (5-6), 692–693.
  • Role of liposome in biosciences. SUNAMOTO, J., AxiYOSIII, K., and SATO, T., Baiosaiensu to Indasutori, 1989, 47, (5), 475–485.
  • Preparation of zein microspheres conjugated with antitumor drugs available for selective cancer chemotherapy and development of a simple colorimetric determination of drugs in inicrospheres. SUZUKI, T., SATO, E., MATSUDA, Y., TADA, H., UNNO, K., and KATO, T., Chem. Pharm. Bull., 1989, 37, (4), 1051–1054.
  • Some structural and functional properties of hemoglobin-containing liposomes (hemosomes), a potential red blood cell substitute. SZEBENI, J., Di Loam, E. E., HAUSER, H., and WINTERHALTER, K. H., Adv. Exp. Med. Biol., 1988, 238, 199–208.
  • Synthesis of gelatin microspheres containing interferon. TABATA, Y., and NADA, Y., Pharm. Res., 19g9, 6, (5), 422–427.
  • Protein precoating of polylactide microspheres containing a lipophilic immunopotentiator for enhancement of macrophage phagocytosis and activation. TABATA, Y., licADA, Pharm. Res., 1989, 6, (4), 296–301.
  • In vivo effects of recombinant interferon alpha A/D incorporated in gelatin microspheres on murine t11/110T cell growth. TABATA, Y., UNO, K., MURAMATSU, S., and NADA, Y., Jpn. J. Cancer Res., 1989, 80, (4), 387–393.
  • Synthesis of gelatin microspheres containing interferon. TABATA, Y., and IKADA, Y., Pharm. Res., 1989, 6, (5), 422–427.
  • Action of pardaxins and their DES analogs on artificial liposomes. TACHIBANA, K., Xu, W. H., BARROW, C. J., blur°, S., Pept. Chem., 1989, 26, 279–284.
  • Interaction of polyamines with phospholipids: spermine and Ca' competition for phospha-tidylserine containing liposomes. TADOLINI, B., and HAKIM, G., Adv. Exp. Med. Biol., 1988, 250, 481–490.
  • The preparation and characteristics studies of microencapsulated cholesteric liquid crystals. I. TAI HUA SHAN, and LEE JIUNN YIH. J. Chin. Inst. Eng., 1989, 12, (2), 233–237.
  • Drug delivery system of anticancer agent entrapped in temperature-sensitive liposomes combined with local hyperthermia. TAKAHASHI, T., KUMAI, K., Immix', K., ABE, 0., TADAKUMA, T., YASUDA, T., and TOMITA, T., Nippon Rinsho, 1989, 47, (6), 1408–1411.
  • Chemoembolization using degradable starch microspheres (DSM) for metastatic liver cancer from the stomach and the colorectum. TAKANO, H., YOSHIKAWA, T., TAK.AHASHI, S., YASUDA, M., NAITO, Y., OYAMADA, H., UEDA, S., TAINAKA, K., ITANI, K., et al. Gastroenterology, 96, (5, Part 2), A665.
  • Trends in research and development of drug delivery systems. TAKAYAMA, K., and NAGAI, T., Nippon Rinsho, 1989, 47, (5), 1197–1205.
  • Control of release of encapsulated molecules from polymerized mixed liposomes induced by physical or chemical stimuli. TAKEOKA, S., OHNO, H., HAYASHI, N., and TSUCHIDA, E., J. Controlled Release, 1989, 9, (2), 177–186.
  • Controlled release theophylline tablet with acrylic polymers prepared by spray-drying technique in aqueous system. TAKEUCHI, H., HANDA, T., and KAWASHIMA, Y., Drug. Dev. Ind. Pharm., 1989, 15, (12), 1999–2016.
  • Effect of positive charge of liposomes on their clearance from the blood and its relation to vesicle lipid composition. TAN, L., GREGORIADIS, G., Biochem. Soc. Trans., 1989, 17, (4), 690–691.
  • Effect of interleukin-2 on the immunoadjuvant action of liposomes. TAN, L., and GREGORIADIS, G., Biochem. Soc. Trans., 1989, 17, (4), 693–694.
  • Photoresponse of a reconstituted membrane containing bacteriorhodopsin observed by using an ion-selective field effect transistor. TANABE, K., HIKUMA, M., SOOMI, L., IwAsmci, Y., TAMIYA, E., and KARUBE, I., J. Biotechnol., 1989, 10, (2), 127–134.
  • Interactions of mixed surfactant solution with liposome membrane. TANAKA, K., TAICEDA, T., NAKAMURA, M., YAMAMURA, S., and MIYAJIMA, K., Colloid Polym. Sci., 1989, 267, (6), 520–524.
  • In vitro targeting and cytotoxicity of adriamycin in liposomes bearing monoclonal antibody against rat or human gp125 cell proliferation-associated antigen. TANAKA, T., Suzum, S., MASUKO, T., and HASHIMOTO, Y., Jpn J. Cancer Res., 1989, 80, (4), 380–386.
  • Permeability of oxidized phosphatidylcholine liposomes. TANFANI, F., and BERTOLI, E., Biochem. Biophys. Res. Commun., 1989, 163, (1), 241–246.
  • Steady-state fluorescence anisotropy and multifrequency phase fluorometry on oxidized phosphatidylcholine vesicles. TANFANI, F., CURATOLA, G., and BERTOLI, E., Chem. Phys. Lipids, 1989, 50, (1), 1–9.
  • Effects of permethrin and cypermethrin on the fluidity of rat erythrocyte ghost membranes. TANG CUYUE, MA TANGENG, and Liu YuGu. Huanjing Kexue Xuebao, 1988, 8, (4), 500–504.
  • The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man. TAYLOR, K. M. G., TAYLOR, G., KELLAWAY, I. W., and STEVENS, J., Pharm. Res., 1989, 6, (7), 633–636.
  • Investigations into the use of gadolinium labeled microspheres (MS) and liposomes (LP) for magnetic resonance imaging (MR.) of lung parenchyma. TFIAKUR, M. L., VINITSKI, S., RIFKIN, M. D., LIN, S., DEFULVIO, J., RICHARD, M. D., MITCHELL, D. M., and LEVY, D., J. Nucl. Med., 1989, 30, (5, Suppl.), 901–902.
  • Amine spin probe permeability in sonicated liposomes. TODD, A. P., MEHLHORN, R. J., and MACEY, R. I., J. Membr. Biol., 1989, 109, (1), 53–64.
  • Nanosphere-coupled and liposome-entrapped anthracyclines potential intracavity therapeu-tics. TOKES, Z. A., SMITH, M. I., FORSSEN, E., DUBEAU, L., JONES, P., and MUGGIA, F. M., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1989, 30, 601.
  • Formulation and evaluation of propylene glycol monostearate microspheres for sustained release of nitrofurantoin. TREK, M. S., University of the Pacific, Stockton, CA, USA, Dissertation, 1988, 154 pp.
  • Oxidative thermal degradation of phenol-formaldehyde copolymer microspheres with modi-fied surface. TRIFONOV, S. A., MALYGIN, A. A., DOLININA, T. B., and KUCHEROV, S. V., Plast. Massy, 1989, (5), 67–69.
  • Immunoliposome complexes: preparation characterization and directed delivery in a human endothelial cell culture. TRUBETSKOI, V. S., TRUBETSKAYA, 0. V., DOMOGATSKII, S. P., and TORCHILIN, V. P., Biol. Membr., 1989, 6, (2), 143–148.
  • Preparation and pharmacokinetic and pharmacodynamic evaluation of hydroxypropyl cellulose-ethyl cellulose microcapsules containing piretanide. TSUJIYAMA, T., Suzum, N., KAWATA, M., UCHIDA, T., and GOTO, S., J. Pharmacobio. Dyn., 1989, 12, (6), 311–323.
  • Pharmacokinetic assessment of acetylated pullulan microcapsules containing oral cephem antibiotics using beagle dogs. UCHIDA, T., FujIMOTO, I., and GOTO, S., Yakuzaigaku, 1989,49, (1), 53–58.
  • Polymerization of allyl alcohol by radiation to obtain microencapsulated structure. USANMAZ, A., and SARICILAR, S., Polym. J., 1989, 21, (4), 281–285.
  • The fidelity of response by 1-(4-(trimethylammonio)pheny1)-6-phenyl-1,3,5-hexatriene in time-resolved fluorescence anisotropy measurements on lipid vesicles. VAN LANGEN, H., VAN GINKEL, G., SHAW, D., and LEVINE, Y. K., Eur. Biophys. J., 1989, 17, (1), 37–48.
  • Photodynamic effects and fluorescence imaging of liposome bound zinc-phthalocyanine observed in vivo in rat tumor transplanted in a sandwich observation chamber. VAN LEENGOED, E., Cuomo, V., VERSTEEG, J., STAR, W., and Join, G., Photochem. Photobiol., 1989,49, (Suppl. ), 4S.
  • Coacervation, complex-coacervation, and flocculation. VAN OSS, C. J., J. Dispersion Sci. Technol., 1989, 9, (5–6), 561–573.
  • Characterization of cell populations, reappearing in the mouse spleen after elimination by liposome encapsulated dichloromethylene diphosphonate: reappearance of marginal zone lymphocytes is independent of marginal zone macrophages. VAN RootiEN, N., KORS, N., and KRAAL, G., Adv. Exp. Med. Biol., 1988, 237, 889–893.
  • Influence of sterols and phospholipids on sarcolemmal and sarcoplasmic reticular cation transporters. VEMURI, R., and PHILIPSON, K. D., J. Biol. Chem., 1989, 264, (15), 8680–8685.
  • Quantitative fluorescence measurement of chloride transport mechanisms in phospholipid vesicles. VERKMAN, A. S., TAKLA, R., SEFTON, B., BASBAUM, C., and WIDDICOMBE, J. H., Biochemistry, 1989, 28, (10), 4240–4244.
  • Influence of size and concentration on liposome calcification. VOGEL, J. J., J. Dent. Res., 1989,68, (Spec. Issue, June), 1016.
  • Model system evaluating fluorescein-labeled microbeads as internal standards to calibrate fluorescence intensity on flow cytometers. VOGT, R. F. Jr, CROSS, G. D., HENDERSON, L. D., and PHILLIPS, D. L., Cytometry, 1989, 10, (3), 294–302.
  • Spin label and microcalorimetric studies of the interaction of DNA with unilamellar phosphatidylcholine liposomes. VOJCIKOVA, L., SVAJDLENKA, E., and BALGAVY, P., Gen. Physiol. Biophys., 1989, 8, (4), 399–406.
  • Preparation of poly(lactic acid) microspheres containing anti-cancer drugs. WADA, R., TABATA, Y., HYON, S. H., and NADA, Y., Bull. Inst. Chem. Res., 1988, 66, (3), 241–250.
  • Entrapment of lipid vesicles and membrane protein-lipid vesicles in gel bead pores. WALLSTEN, M., YANG, Q., and LUNDAHL, P., Biochim. Biophys. Acta., 1989, 982, (1), 47–52.
  • Regional cerebral distribution of microspheres and technitium-99M ECD in nonhuman primates. WALOVITCH, R. O., PLATTS, S. H., WALSH, R. A., and ORLANDI, C., J. Nucl. Med., 1989, 30, (5, Suppl.), 792.
  • Effect of gramicidin on the ion permeability of liposomes in the presence of mixed electrolytes. WATANABE, S., WATANABE, S., and SENO, M., J. Membr. Sci., 1989,44, (2-3), 253–264.
  • Alloxan-induced alterations in composition and dynamics of red blood cell membranes I. Effect of alloxan on intact red blood cells and isolated erythrocyte membranes. WATALA, C., BUDZIEJEWSKA, A., and Jozwiikx, Z., Biochem. Pharmacol., 1989, 38, (11), 1793–1798.
  • Effect of gramicidin on the ion permeability of liposomes in the presence of mixed electrolytes. WATANABE, S., WATANABE, S., and SENO, M., J. Membr. Sci., 1989, 44, (2-3), 253–264.
  • Stability in biological fluids and clearance of immunoliposomes. WECKENMANN, H. P., MATZKUI, S., STRICKER, H., and SINN, H., Arzneimittelforschung, 1989, 39, (3), 415–420.
  • Liposomes as carriers for polypeptides. WEINER, A. L., Adv. Drug. Delivery Rev., 1989, 3, (3), 307–341.
  • Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model. WEINER, N., WILLIAMS, N., BIRCH, G., RAMACHANDRAN, C., SHIPMAN, C. Jr, and FLYNN, G., Antimicrob. Agents Chemother., 1989, 33, (8), 1217–1221.
  • Liposomes as a drug delivery system. WEINER, N., MARTIN, F., and RIAZ, M., Drug. Dev. Ind. Pharm., 1989, 15, (10), 1523–1554.
  • Aluminum-altered membrane dynamics in human red blood cell white ghosts. WEIS, C., and HAUG, A., Thromb. Res., 1989, 54, (2), 141–149.
  • Covalent coupling of sugars to liposomes. WEISSIG, V., LASCH, J., and GREGORIADIS, G., Biochim. Biophys. Acta, 1989, 1003, (1), 54–57.
  • Differential effects of phosphatidylcholine liposomes and vitamin E on three different liver injury models in mice. WERNER, C., Naunyn Schmiedeberg's Arch. Pharmacol., 1989, 339, (Suppl.), R7.
  • Reconstitution of glucose transport activity in liposomes to test proposed modulators of the transporter. WHEELER, T. J., In Progress in Clinical and Biological Research, D. A. BUTTERFIELD (ed.) (A. R. Liss: New York, USA), 1989, vol. 292, pp. 349–358.
  • Synthesis and characterization of biodegradable microparticles on a polyactide basis. WICHERT, B., and ROHDEWALD, P., Arch. Pharm. Weinheini, 1988, 321, (9), 686.
  • Biodegradation rate of embolized protein microspheres in lung, liver and kidney of rats. WILLMOTT, N., CHEN YAN, GOLDBERG, J., MCARDLE, C., and FLORENCE, A. T., J. Pharm. Pharmacol., 1989, 41, (7), 433–438.
  • Binding of plasmodium berghei proteins to inside-out vesicles prepared from erythrocyte ghosts. WISER, M. F., SARTORELLI, A. C., and PATTON, C. L., J. Cell Biochem. Supp., 1989, (13, Part E), 158.
  • Penetration of lecithin from hydrocortisone-containing liposomes into human skin. WOHLRAB, W., LACHMANN, U., and LASCH, J., Dermatol. Monatsschr, 1989, 175, (6), 344–347.
  • The effect of liposomal incorporation of topically applied hydrocortisone on its serum concentration and urinary excretion. WOHLRAB, W., and LASCH, J., Dermatol. Monatsschr., 1989, 175, (6), 348–352.
  • Skin permeation of liposomal incorporated hydrocortisone. WOHLRAB, W., LASCH, J., TAUBE, K. M., and WOZNIAK, K. D., Pharmazie, 1989, 44, (5), 333–335.
  • Intracellular killing of Mycobacterium avium by macrophages stimulated with liposome tumor necrosis factor (LP-TNF). Wu, M., BERMUDEZ, L. E., and YOUNG, L. S., Abstr. Annu. Meet. Am. Soc. Microbiol., 1989, 89, 166.
  • Potentiometric enzyme-amplified flow injection analysis detection system: behavior of free and liposome-released peroxidase. Wu TAI GUANG, BELLAMA, J. M., and DURST, R. A., Anal. Lett., 1989, 22, (5), 1107–1124.
  • Immunoadjuvant action of liposomes for entrapped poliovirus peptide. XIAO QIFU, GREGORIADIS, G., and FERGUSON, M., Biochem. Soc. Trans., 1989, 17, (4), 695.
  • Reconstitution of Pseudomonas maltophilia HCG receptor to liposomes by dialysis method. XIE, B., CHEN, M. L., LEI, Y. D., WANG, D. G., Li, L., LI, G. R., GAN, D. 0., and LAN, T. H., Hua Hsi I Ko Ta Hsueh Hsueh Pao, 1988, 19, (3), 235–237.
  • Studies on the preparation of ATP/ATP liposomes. Xu, G. X., and Xis, X. H., Acta Pharm. Sin., 1989, 24, (2), 133–138.
  • Targeting therapy of gastrointestinal cancers with sulfatide-inserted liposomes entrapping adriamycin. YAGUCHI, T., YAMAUCHI, M., NAGATA, J., TAKAGI, H., HAYASHI, Y., OHISHI, S., and YAGI, K., Nippon Rinsho, 1989, 47, (6), 1369–1372.
  • An automated methods for measurement of lecithin cholesterol acyltransferase activities in serum using liposome as the substrate. YAMADA, M., KOBAYASHI, I., and OHNISHI, M., Rinsho Kensa, 1989, 33, (4), 461–465.
  • Antioxidative activities of alpha-tocotrienol and its derivative in the oxidation of dilinoleoyl-phosphatidylcholine liposomes. YAMAOKA, M., and KOMIYAMA, K., Yukagaku, 1989, 38, (6), 478–485.
  • Clinical application and significance of drug delivery systems. Prostaglandins. YANAGAWA, A., and HARAMOTO, S., Nippon Rinsho, 1989, 47, (6), 1316–1323.
  • Chemoembolization with microsphere of silicon-adriamycin composite. YANAGIYA, K., MIZUTANI, Y., and OKAMURA, D., Nippon Rinsho, 1989, 47, (6), 1373–1378.
  • DNA trapping by liposomes prepared by dehydration and rehydration method: factors affecting trapping efficiency. YIN CHANGCHENG, SHEN ZIWEI, ZHAO NANMING, TANG HUIXIAN, and JIA SHIRONG, Shengwu Huaxue Yu Shengwu Wuli Jinzhan, 1989, 16, (1), 52.
  • Targeted and sustained delivery of aclarubicin to lymphatics by lactic acid-oligomer microsphere in rat. YOSHIKAWA, H., NAKAO, Y., TAKADA, K., MURANISHI, S., WADA, R.. TABATA, Y., HYON, S. H., and IKADA, Y., Chem. Pharm. Bull., 1989, 37, (3), 802–804.
  • 'Super microcapsules' (SMC). I. Preparation and characterization of star polyethylene oxide (PEO)- polylactide (PLA) copolymers. Zliu, K. J., SONG, B., and YANG, S., J. Polym. Sci., Part A: Polym. Chem., 1989, 27, (7), 2151–2159.
  • Studies on the stability and some other important physical properties of polysaccharide polyphase liposome (PPL). Zou, Y. Y., Su, D. S., HAN, G. C., and Gu, X. Q., Acta Pharm. Sin., 1989, 24, (1), 58–62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.